99 results on '"AI, artificial intelligence"'
Search Results
2. Medications and Patient Factors Associated With Increased Readmission for Alcohol-Related Diagnoses
- Author
-
Joseph C. Osborne, Susan E. Horsman, Kristin C. Mara, Thomas C. Kingsley, Robert W. Kirchoff, and Jonathan G. Leung
- Subjects
Medicine (General) ,R5-920 ,AUD, alcohol use disorder ,AWS, alcohol withdrawal syndrome ,CCI, Charlson comorbidity index ,BMI, body mass index ,Original Article ,AI, artificial intelligence ,CIWA, clinical institute withdrawal assessment ,LOS, length of stay - Abstract
Objective: To investigate medication factors and patient characteristics associated with readmissions following alcohol-related hospitalizations. Patients and Methods: Adult patients admitted from September 1, 2016, through August 31, 2019, who had an alcohol-related hospitalization were identified through electronic health records. Patient characteristics and medications of interest administered during hospitalization or prescribed at discharge were identified. Medications of interest included US Food and Drug Administration–approved medications for alcohol use disorder, benzodiazepines, barbiturates, gabapentin, opioids, and muscle relaxants. The primary outcome was to identify medications and patient factors associated with 30-day alcohol-related readmission. Secondary outcomes included medications and patient characteristics associated with multiple alcohol-related readmissions within a year from the index admission (ie, two or more readmissions) and factors associated with 30-day all-cause readmission. Results: Characteristics of the 932 patients included in this study associated with a 30-day alcohol-related readmission included younger age, severity of alcohol withdrawal, history of psychiatric disorder, marital status, and the number of prior alcohol-related admission in the previous year. Benzodiazepine or barbiturate use during hospitalization or upon discharge was associated with 30-day alcohol-related readmission (P=.006). Gabapentin administration during hospitalization or upon discharge was not associated with 30-day alcohol-related readmission (P=.079). Conclusion: The findings reinforce current literature identifying patient-specific factors associated with 30-day readmissions. Gabapentin use was not associated with readmissions; however, there was an association with benzodiazepine/barbiturate use.
- Published
- 2021
3. Applying artificial intelligence for cancer immunotherapy
- Author
-
Xiang Wang, Zhicheng Gong, Yuanliang Yan, Xinxin Ren, Shuangshuang Zeng, and Zhijie Xu
- Subjects
Risk analysis ,Artificial intelligence ,CTLA-4, cytotoxic T lymphocyte-associated antigen 4 ,Computer science ,medicine.medical_treatment ,Diagnostic accuracy ,Cancer immunotherapy ,Review ,MMR, mismatch repair ,RM1-950 ,MHC-I, major histocompatibility complex class I ,TNBC, triple-negative breast cancer ,PD-1, programmed cell death protein 1 ,03 medical and health sciences ,0302 clinical medicine ,Machine learning ,medicine ,ICB, immune checkpoint blockade ,ML, machine learning ,General Pharmacology, Toxicology and Pharmaceutics ,Diagnostics ,030304 developmental biology ,0303 health sciences ,DL, deep learning ,US, ultrasonography ,business.industry ,CT, computed tomography ,irAEs, immune-related adverse events ,ComputingMethodologies_PATTERNRECOGNITION ,Software deployment ,030220 oncology & carcinogenesis ,AI, artificial intelligence ,Health information ,Therapeutics. Pharmacology ,PD-L1, PD-1 ligand1 ,business ,MRI, magnetic resonance imaging - Abstract
Artificial intelligence (AI) is a general term that refers to the use of a machine to imitate intelligent behavior for performing complex tasks with minimal human intervention, such as machine learning; this technology is revolutionizing and reshaping medicine. AI has considerable potential to perfect health-care systems in areas such as diagnostics, risk analysis, health information administration, lifestyle supervision, and virtual health assistance. In terms of immunotherapy, AI has been applied to the prediction of immunotherapy responses based on immune signatures, medical imaging and histological analysis. These features could also be highly useful in the management of cancer immunotherapy given their ever-increasing performance in improving diagnostic accuracy, optimizing treatment planning, predicting outcomes of care and reducing human resource costs. In this review, we present the details of AI and the current progression and state of the art in employing AI for cancer immunotherapy. Furthermore, we discuss the challenges, opportunities and corresponding strategies in applying the technology for widespread clinical deployment. Finally, we summarize the impact of AI on cancer immunotherapy and provide our perspectives about underlying applications of AI in the future., Graphical abstract With the increasing of clinical data and advanced AI methodologies, AI-based technologies have the potential to increase the functional roles in cancer immunotherapy response.Image 1
- Published
- 2021
4. Artificial intelligence in clinical care amidst COVID-19 pandemic: A systematic review
- Author
-
Konstantina S. Nikita, Eleni S. Adamidi, and Konstantinos Mitsis
- Subjects
LR, Logistic Regression ,APTT, Activated Partial Thromboplastin Time ,DNN, Deep Neural Networks ,GNB, Gaussian Naïve Bayes ,RSV, Respiratory Syncytial Virus ,SVM, Support Vector Machine ,Review ,Disease ,Biochemistry ,WBC, White Blood Cell count ,0302 clinical medicine ,Multimodal data ,DLC, Density Lipoprotein Cholesterol ,Medicine ,CPP, COVID-19 Positive Patients ,Nadam optimizer, Nesterov Accelerated Adaptive Moment optimizer ,0303 health sciences ,CRT, Classification and Regression Decision Tree ,Prognosis ,LDLC, Low Density Lipoprotein Cholesterol ,CRP, C-Reactive Protein ,GFS, Gradient boosted feature selection ,LDA, Linear Discriminant Analysis ,Systematic review ,ADA, Adenosine Deaminase ,ML, Machine Learning ,CNN, Convolutional Neural Networks ,030220 oncology & carcinogenesis ,GGT, Glutamyl Transpeptidase ,RBP, Retinol Binding Protein ,RF, Random Forest ,NLP, Natural Language Processing ,INR, International Normalized Ratio ,LASSO, Least Absolute Shrinkage and Selection Operator ,FCV, Fold Cross Validation ,SEN, Sensitivity ,Biophysics ,ABG, Arterial Blood Gas ,SRLSR, Sparse Rescaled Linear Square Regression ,RBF, Radial Basis Function ,AI, Artificial Intelligence ,03 medical and health sciences ,PWD, Platelet Distribution Width ,RFE, Recursive Feature Elimination ,Genetics ,OB, Occult Blood test ,Paco2, Arterial Carbondioxide Tension ,MLP, MultiLayer Perceptron ,DL, Deep Learning ,ED, Emergency Department ,Guideline ,CI, Confidence Interval ,ANN, Artificial Neural Networks ,GFR, Glomerular Filtration Rate ,MPV, Mean Platelet Volume ,TBA, Total Bile Acid ,Adaboost, Adaptive Boosting ,TP248.13-248.65 ,MCV, Mean corpuscular volume ,ET, Extra Trees ,Artificial intelligence ,L1LR, L1 Regularized Logistic Regression ,MCHC, Mean Corpuscular Hemoglobin Concentration ,ARMED, Attribute Reduction with Multi-objective Decomposition Ensemble optimizer ,CK-MB, Creatine Kinase isoenzyme ,LSTM, Long-Short Term Memory ,FL, Federated Learning ,PCT, Thrombocytocrit ,Structural Biology ,Pandemic ,Diagnosis ,TTS, Training Test Split ,HDLC, High Density Lipoprotein Cholesterol ,PPV, Positive Predictive Values ,k-NN, K-Nearest Neighbor ,Computer Science Applications ,BUN, Blood Urea Nitrogen ,FiO2, Fraction of Inspiration O2 ,RBC, Red Blood Cell ,SG, Specific Gravity ,GDCNN, Genetic Deep Learning Convolutional Neural Network ,Screening ,XGB, eXtreme Gradient Boost ,Apol B, Apolipoprotein B ,GBDT, Gradient Boost Decision Tree ,PaO2, Arterial Oxygen Tension ,Biotechnology ,NB, Naïve Bayes ,Coronavirus disease 2019 (COVID-19) ,Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) ,SMOTE, Synthetic Minority Oversampling Technique ,Apol AI, Apolipoprotein AI ,CoxPH, Cox Proportional Hazards ,Acc, Accuracy ,AUC, Area Under the Curve ,ComputingMethodologies_COMPUTERGRAPHICS ,030304 developmental biology ,ESR, Erythrocyte Sedimentation Rate ,LDH, Lactate Dehydrogenase ,BNB, Bernoulli Naïve Bayes ,business.industry ,RDW, Red blood cell Distribution Width ,NPV, Negative Predictive Values ,GBM light, Gradient Boosting Machine light ,DCNN, Deep Convolutional Neural Networks ,SPE, Specificity ,COVID-19 ,Inception Resnet, Inception Residual Neural Network ,DT, Decision Tree ,MRMR, Maximum Relevance Minimum Redundancy ,SaO2, Arterial Oxygen saturation ,business ,Predictive modelling - Abstract
Graphical abstract, The worldwide health crisis caused by the SARS-Cov-2 virus has resulted in>3 million deaths so far. Improving early screening, diagnosis and prognosis of the disease are critical steps in assisting healthcare professionals to save lives during this pandemic. Since WHO declared the COVID-19 outbreak as a pandemic, several studies have been conducted using Artificial Intelligence techniques to optimize these steps on clinical settings in terms of quality, accuracy and most importantly time. The objective of this study is to conduct a systematic literature review on published and preprint reports of Artificial Intelligence models developed and validated for screening, diagnosis and prognosis of the coronavirus disease 2019. We included 101 studies, published from January 1st, 2020 to December 30th, 2020, that developed AI prediction models which can be applied in the clinical setting. We identified in total 14 models for screening, 38 diagnostic models for detecting COVID-19 and 50 prognostic models for predicting ICU need, ventilator need, mortality risk, severity assessment or hospital length stay. Moreover, 43 studies were based on medical imaging and 58 studies on the use of clinical parameters, laboratory results or demographic features. Several heterogeneous predictors derived from multimodal data were identified. Analysis of these multimodal data, captured from various sources, in terms of prominence for each category of the included studies, was performed. Finally, Risk of Bias (RoB) analysis was also conducted to examine the applicability of the included studies in the clinical setting and assist healthcare providers, guideline developers, and policymakers.
- Published
- 2021
5. A review on machine learning approaches and trends in drug discovery
- Author
-
Victor Maojo, Nereida Rodriguez-Fernandez, Adrian Carballal, Carlos Fernandez-Lozano, Francisco J. Novoa, Alejandro Pazos, Paula Carracedo-Reboredo, Francisco Cedrón, and Jose Liñares-Blanco
- Subjects
GNN, Graph Neural Networks ,Computer science ,CPI, Compound-protein interaction ,Review ,computer.software_genre ,NB, Naive Bayes ,FNN, Fully Connected Neural Networks ,Biochemistry ,Field (computer science) ,AUC, Area under the Curve ,PCA, Principal Component Analyisis ,Machine Learning ,DNA, Deoxyribonucleic acid ,ADMET, Absorption, distribution, metabolism, elimination and toxicity ,Structural Biology ,Drug Discovery ,MCC, Matthews correlation coefficient ,GEO, Gene Expression Omnibus ,t-SNE, t-Distributed Stochastic Neighbor Embedding ,Drug discovery ,QSAR ,Cheminformatics ,BBB, Blood–Brain barrier ,OOB, Out of Bag ,Molecular Descriptors ,Computer Science Applications ,CNS, Central Nervous System ,MKL, Multiple Kernel Learning ,ML, Machine Learning ,CNN, Convolutional Neural Networks ,RF, Random Forest ,Biotechnology ,CV, Cross Validation ,SVM, Support Vector Machines ,Quantitative structure–activity relationship ,GCN, Graph Convolutional Networks ,MACCS, Molecular ACCess System ,Biophysics ,QSAR, Quantitative structure–activity relationship ,FP, Fringerprints ,Machine learning ,SMILES, simplified molecular-input line-entry system ,ADR, Adverse Drug Reaction ,KEGG, Kyoto Encyclopedia of Genes and Genomes ,WHO, World Health Organization ,MD, Molecular Descriptors ,AI, Artificial Intelligence ,Deep Learning ,Component (UML) ,GO, Gene Ontology ,ECFP, Extended Connectivity Fingerprints ,Genetics ,Set (psychology) ,ComputingMethodologies_COMPUTERGRAPHICS ,APFP, Atom Pairs 2d FingerPrint ,business.industry ,DL, Deep Learning ,Deep learning ,CDK, Chemical Development Kit ,RNA, Ribonucleic Acid ,FDA, Food and Drug Administration ,ANN, Artificial Neural Networks ,FS, Feature Selection ,TCGA, The Cancer Genome Atlas ,State (computer science) ,Artificial intelligence ,business ,computer ,TP248.13-248.65 - Abstract
Graphical abstract, Highlights • Machine Learning in drug discovery has greatly benefited the pharmaceutical industry. • Application of machine algorithms must entail a robust design in real clinical tasks. • Trending machine learning algorithms in drug design: NB, SVM, RF and ANN., Drug discovery aims at finding new compounds with specific chemical properties for the treatment of diseases. In the last years, the approach used in this search presents an important component in computer science with the skyrocketing of machine learning techniques due to its democratization. With the objectives set by the Precision Medicine initiative and the new challenges generated, it is necessary to establish robust, standard and reproducible computational methodologies to achieve the objectives set. Currently, predictive models based on Machine Learning have gained great importance in the step prior to preclinical studies. This stage manages to drastically reduce costs and research times in the discovery of new drugs. This review article focuses on how these new methodologies are being used in recent years of research. Analyzing the state of the art in this field will give us an idea of where cheminformatics will be developed in the short term, the limitations it presents and the positive results it has achieved. This review will focus mainly on the methods used to model the molecular data, as well as the biological problems addressed and the Machine Learning algorithms used for drug discovery in recent years.
- Published
- 2021
6. Learning 4.0 - Ambition Guide
- Author
-
Nogueira, Marcos Ant��nio, Nunes, Elsa, Henriques, Rui Pedro, Vishniakova, Elena, and Peir��, Paula
- Subjects
Digitalisation ,Skills ,AI, Artificial intelligence ,Communities ,Learning - Abstract
The goal is to build a human-centric, sustainable society of the prosperous future for all citizens, the European union has been adopting visions for digital transformation of Europe by 2030. This ambition guide’s section outlines the broader landscape of European initiatives that orient projectsat any level in planning and implementing a coherent roadmap for a successful smart transformation. Thus, projects implementing this ambition guide may also align with the following strategies, visions and platforms.
- Published
- 2022
- Full Text
- View/download PDF
7. Using AI chatbots to provide self-help depression interventions for university students: A randomized trial of effectiveness☆
- Author
-
Hao Liu, Huaming Peng, Xingyu Song, Chenzi Xu, and Meng Zhang
- Subjects
ANOVA, Analysis of Variance ,CSQ-8, the Client Satisfaction Questionnaires-8 ,Health Informatics ,Information technology ,CBT, Cognitive Behavioral Therapy ,SD, Standard Deviation ,DST, Dialogue Status Tracking ,T58.5-58.64 ,PANAS, the Positive and Negative Affect Schedule (PANAS) (Watson et al., 19s88) ,Full length Article ,BF1-990 ,AI, Artificial Intelligence ,GAD-7, the Generalized Anxiety Disorder Scale-7 (GAD-7) ,DPO, Dialogue Policy Optimization ,mHealth ,PHQ-9, the Patient Health Questionnaires-9 ,WAI-SR, the Working Alliance Inventory-Short Revised ,Psychology ,AI Artificial Intelligence ,IPI, Internet-based Psychological Interventions ,ANCONA, Analysis of Covariance ,ITT, Intent-to-Treat ,Public health informatics - Abstract
Background Depression impacts the lives of a large number of university students. Mobile-based therapy chatbots are increasingly being used to help young adults who suffer from depression. However, previous trials have short follow-up periods. Evidence of effectiveness in pragmatic conditions are still in lack. Objective This study aimed to compare chatbot therapy to bibliotherapy, which is a widely accepted and proven-useful self-help psychological intervention. The main objective of this study is to add to the evidence of effectiveness for chatbot therapy as a convenient, affordable, interactive self-help intervention for depression. Methods An unblinded randomized controlled trial with 83 university students was conducted. The participants were randomly assigned to either a chatbot test group (n = 41) to receive a newly developed chatbot-delivered intervention, or a bibliotherapy control group (n = 42) to receive a minimal level of bibliotherapy. A set of questionnaires was implemented as measurements of clinical variables at baseline and every 4 weeks for a period of 16 weeks, which included the Patient Health Questionnaire-9 (PHQ-9), the Generalized Anxiety Disorder scale (GAD-7), the Positive and Negative Affect Scale (PANAS). The Client Satisfaction Questionnaire-8 (CSQ-8) and the Working Alliance Inventory-Short Revised (WAI-SR) were used to measure satisfaction and therapeutic alliance after the intervention. Participants' self-reported adherence and feedback on the therapy chatbot were also collected. Results Participants were all university students (undergraduate students (n = 31), postgraduate students (n = 52)). They were between 19 and 28 years old (mean = 23.08, standard deviation (SD) = 1.76) and 55.42% (46/83) female. 24.07% (20/83) participants were lost to follow-up. No significant group difference was found at baseline. In the intention-to-treat analysis, individuals in the chatbot test group showed a significant reduction in the PHQ-9 scores (F = 22.89; P, Highlights • A chatbot-delivered depression therapy was compared to a minimal level of bibliotherapy in a 16-week follow-up period. • The therapy chatbot was able to provide depression intervention under cognitive behavioral therapy (CBT) principles. • The therapy chatbot reduced depression in the 16 weeks intervention period and reduced anxiety in the first 4 weeks. • A significantly better therapeutic alliance was achieved in the chatbot-delivered therapy compared to the bibliotherapy.
- Published
- 2022
8. Sex-Specific Molecular Signatures of Fibrocalcific Aortic Valve Disease
- Author
-
Holger Thiele and Florian Schlotter
- Subjects
Aortic valve ,Aortic valve disease ,sex differences ,medicine.medical_specialty ,AS, aortic stenosis ,calcification ,Clinical Research ,Internal medicine ,medicine ,Diseases of the circulatory (Cardiovascular) system ,ML, machine learning ,PCA, principal component analysis ,business.industry ,CABG, coronary artery bypass graft ,fibrosis ,stenosis ,aortic stenosis ,medicine.disease ,artificial intelligence ,Sex specific ,aortic valve ,Stenosis ,medicine.anatomical_structure ,RC666-701 ,Cardiology ,AI, artificial intelligence ,Cardiology and Cardiovascular Medicine ,business ,Editorial Comment ,sex-differences ,Calcification - Abstract
Visual Abstract, Highlights • Differences in the clinical presentation and physiology of aortic stenosis in men and women complicate the management of the condition. • By combining traditional inferential statistics, artificial intelligence predictive modeling, and genetic pathway analysis, one can gain further insight into sex-specific gene expression patterns, potentially driving the valvular phenotype differences between the sexes. • Results from this study, implementing a mixed and comprehensive methodological approach, offer a foundation for further exploration of potential drug targets., Summary Male and female aortic stenosis patients have distinct valvular phenotypes, increasing the complexities in the evaluation of valvular pathophysiology. In this study, we present cutting-edge artificial intelligence analyses of transcriptome-wide array data from stenotic aortic valves to highlight differences in gene expression patterns between the sexes, using both sex-differentiated transcripts and unbiased gene selections. This approach enabled the development of efficient models with high predictive ability and determining the most significant sex-dependent contributors to calcification. In addition, analyses of function-related gene groups revealed enriched fibrotic pathways among female patients. Ultimately, we demonstrate that artificial intelligence models can be used to accurately predict aortic valve calcification by carefully analyzing sex-specific gene transcripts.
- Published
- 2021
9. Artificial intelligence (AI) and big data in cancer and precision oncology
- Author
-
Zodwa Dlamini, Rodney Hull, Flavia Zita Francies, and Rahaba Marima
- Subjects
Biomarker identification ,Artificial intelligence ,Risk predictor ,WSI, Whole Slide Imaging ,Computer science ,lcsh:Biotechnology ,Big data ,Biophysics ,Early detection ,Review ,FFPE, Formalin-Fixed Paraffin-Embedded ,Biochemistry ,AI, Artificial Intelligence ,Prognosis and drug discovery ,03 medical and health sciences ,0302 clinical medicine ,Structural Biology ,lcsh:TP248.13-248.65 ,Diagnosis ,Machine learning ,Genetics ,medicine ,Digital pathology ,ComputingMethodologies_COMPUTERGRAPHICS ,030304 developmental biology ,0303 health sciences ,business.industry ,LYNA, LYmph Node Assistant ,Cancer ,Deep learning ,Precision oncology ,medicine.disease ,Computer Science Applications ,Treatment ,Identification (information) ,CNV, Copy Number Variations ,Big datasets ,ML, Machine Learning ,030220 oncology & carcinogenesis ,TCGA, The Cancer Genome Atlas ,Medical imaging ,business ,NGS, Next Generation Sequencing ,NGS and bioinformatics ,Biotechnology - Abstract
Graphical abstract, Artificial intelligence (AI) and machine learning have significantly influenced many facets of the healthcare sector. Advancement in technology has paved the way for analysis of big datasets in a cost- and time-effective manner. Clinical oncology and research are reaping the benefits of AI. The burden of cancer is a global phenomenon. Efforts to reduce mortality rates requires early diagnosis for effective therapeutic interventions. However, metastatic and recurrent cancers evolve and acquire drug resistance. It is imperative to detect novel biomarkers that induce drug resistance and identify therapeutic targets to enhance treatment regimes. The introduction of the next generation sequencing (NGS) platforms address these demands, has revolutionised the future of precision oncology. NGS offers several clinical applications that are important for risk predictor, early detection of disease, diagnosis by sequencing and medical imaging, accurate prognosis, biomarker identification and identification of therapeutic targets for novel drug discovery. NGS generates large datasets that demand specialised bioinformatics resources to analyse the data that is relevant and clinically significant. Through these applications of AI, cancer diagnostics and prognostic prediction are enhanced with NGS and medical imaging that delivers high resolution images. Regardless of the improvements in technology, AI has some challenges and limitations, and the clinical application of NGS remains to be validated. By continuing to enhance the progression of innovation and technology, the future of AI and precision oncology show great promise.
- Published
- 2020
10. Rapid Exclusion of COVID Infection With the Artificial Intelligence Electrocardiogram
- Author
-
Zachi I. Attia, Naveen L. Pereira, Anneli Svensson, Francisco Fernández-Avilés, Thomas F Luescher, Raja Sekhar Madathala, Jozef Bartunek, John Halamka, Henrik Jensen, Francisco Lopez Jimenez, Paari Dominic, Pyotr G. Platonov, Domenico Zagari, Pahlajani Db, Nikhita R Chennaiah Gari, Marco Merlo, Darryl D Esakof, Vladan Vukomanovic, John Signorino, Daniel C. DeSimone, Gianfranco Sinagra, Stefan Janssens, Kevin P. Cohoon, Francis J. Alenghat, Jennifer L. Dugan, Karl Dujardin, Melody Hermel, Michael E. Farkouh, Goran Loncar, Sanjiv M. Narayan, Suraj Kapa, Deepak Padmanabhan, Karam Turk-Adawi, Rickey E. Carter, Paul A. Friedman, Carolyn Lam Su Ping, Fahad Gul, Amit Noheria, Nidal Asaad, Arun Sridhar, Gaetano Antonio Lanza, Peter A. Noseworthy, Nicholas S. Peters, Marc K. Lahiri, Jessica Cruz, Brenda D Rodriguez Escenaro, Gaurav A. Upadhyay, Jose Alberto Pardo Gutierrez, Attia, Z. I., Kapa, S., Dugan, J., Pereira, N., Noseworthy, P. A., Jimenez, F. L., Cruz, J., Carter, R. E., Desimone, D. C., Signorino, J., Halamka, J., Chennaiah Gari, N. R., Madathala, R. S., Platonov, P. G., Gul, F., Janssens, S. P., Narayan, S., Upadhyay, G. A., Alenghat, F. J., Lahiri, M. K., Dujardin, K., Hermel, M., Dominic, P., Turk-Adawi, K., Asaad, N., Svensson, A., Fernandez-Aviles, F., Esakof, D. D., Bartunek, J., Noheria, A., Sridhar, A. R., Lanza, G. A., Cohoon, K., Padmanabhan, D., Pardo Gutierrez, J. A., Sinagra, G., Merlo, M., Zagari, D., Rodriguez Escenaro, B. D., Pahlajani, D. B., Loncar, G., Vukomanovic, V., Jensen, H. K., Farkouh, M. E., Luescher, T. F., Su Ping, C. L., Peters, N. S., and Friedman, P. A.
- Subjects
COVID-19, coronavirus infectious disease 19 ,COVID-19/diagnosis ,Coronavirus disease 2019 (COVID-19) ,Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) ,Population ,Predictive Value of Test ,ACE2, angiotensin-converting enzyme 2 ,SARS-CoV-2, severe acute respiratory syndrome coronavirus 2 ,Sensitivity and Specificity ,WHO, World Health Organization ,AUC, area under the curve ,Electrocardiography ,COVID-19 ,Case-Control Studies ,Humans ,Predictive Value of Tests ,Artificial Intelligence ,PCR, polymerase chain reaction ,Medicine ,education ,Volunteer ,education.field_of_study ,medicine.diagnostic_test ,business.industry ,Area under the curve ,Case-control study ,AI-ECG, artificial intelligence–enhanced electrocardiogram ,REDCap, Research Electronic Data Capture ,General Medicine ,PPV, positive predictive value ,NPV, negative predictive value ,Predictive value of tests ,Screening ,Original Article ,AI, artificial intelligence ,Artificial intelligence ,business ,Case-Control Studie ,COVID 19 ,Human - Abstract
OBJECTIVE: To rapidly exclude severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection using artificial intelligence applied to the electrocardiogram (ECG).METHODS: A global, volunteer consortium from 4 continents identified patients with ECGs obtained around the time of polymerase chain reaction-confirmed COVID-19 diagnosis and age- and sex-matched controls from the same sites. Clinical characteristics, polymerase chain reaction results, and raw electrocardiographic data were collected. A convolutional neural network was trained using 26,153 ECGs (33.2% COVID positive), validated with 3826 ECGs (33.3% positive), and tested on 7870 ECGs not included in other sets (32.7% positive). Performance under different prevalence values was tested by adding control ECGs from a single high-volume site.RESULTS: The area under the curve for detection of acute COVID-19 infection in the test group was 0.767 (95% CI, 0.756 to 0.778; sensitivity, 98%; specificity, 10%; positive predictive value, 37%; negative predictive value, 91%). To more accurately reflect a real-world population, 50,905 normal controls were added to adjust the COVID prevalence to approximately 5% (2657/58,555), resulting in an area under the curve of 0.780 (95% CI, 0.771 to 0.790) with a specificity of 12.1% and a negative predictive value of 99.2%.CONCLUSION: Infection with SARS-CoV-2 results in electrocardiographic changes that permit the artificial intelligence-enhanced ECG to be used as a rapid screening test with a high negative predictive value (99.2%). This may permit the development of electrocardiography-based tools to rapidly screen individuals for pandemic control.
- Published
- 2021
- Full Text
- View/download PDF
11. SARS-CoV-2 diagnosis using medical imaging techniques and artificial intelligence: A review
- Author
-
Mohamed Hedi Bedoui, Ramzi Mahmoudi, Younes Arous, Narjes Benameur, Badii Hmida, Soraya Zaid, Laboratoire d'Informatique Gaspard-Monge (LIGM), Université Paris-Est Marne-la-Vallée (UPEM)-École des Ponts ParisTech (ENPC)-ESIEE Paris-Fédération de Recherche Bézout-Centre National de la Recherche Scientifique (CNRS), and Centre National de la Recherche Scientifique (CNRS)-Fédération de Recherche Bézout-ESIEE Paris-École des Ponts ParisTech (ENPC)-Université Paris-Est Marne-la-Vallée (UPEM)
- Subjects
CNN, Convolutional neural network ,Pleural effusion ,Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) ,viruses ,CXR, Chest X-ray ,Clinical Findings ,Article ,030218 nuclear medicine & medical imaging ,[INFO.INFO-AI]Computer Science [cs]/Artificial Intelligence [cs.AI] ,03 medical and health sciences ,0302 clinical medicine ,Chest CT ,DNN, Deep neural network ,GAN, Generative adversarial network ,Medical Imaging Techniques ,Artificial Intelligence ,Medical imaging ,medicine ,[INFO.INFO-IM]Computer Science [cs]/Medical Imaging ,Radiology, Nuclear Medicine and imaging ,[INFO]Computer Science [cs] ,skin and connective tissue diseases ,Modality (human–computer interaction) ,business.industry ,SARS-CoV-2 ,AI, Artificial intelligence ,fungi ,GGO, Ground-glass opacities ,medicine.disease ,3. Good health ,respiratory tract diseases ,body regions ,Workflow ,Pneumothorax ,Radiology Nuclear Medicine and imaging ,030220 oncology & carcinogenesis ,CT, Computed tomography ,Identification (biology) ,Artificial intelligence ,Reticular Pattern ,business - Abstract
International audience; Objective: SARS-CoV-2 is a worldwide health emergency with unrecognized clinical features. This paper aims to review the most recent medical Imaging techniques used for the diagnosis of SARS-CoV-2 and their potential contributions to attenuate the pandemic. Recent researches, including Artificial Intelligence tools, will be described. Methods We review the main clinical features of SARS-CoV-2 revealed by different medical imaging techniques. First, we present the clinical findings of each technique. Then, we describe several artificial intelligence approaches introduced for the SARS-CoV-2 diagnosis. Results CT is the most accurate diagnostic modality of SARS-CoV-2. Additionally, ground-glass opacities and consolidation are the most common signs of SARS-CoV-2 in CT images. However, other findings such as reticular pattern, and crazy paving could be observed. We also found that pleural effusion and pneumothorax features are less common in SARS-CoV-2. According to the literature, the B lines artifacts and pleural line irregularities are the common signs of SARS-CoV-2 in ultrasound images. We have also stated the different studies, focusing on artificial intelligence tools, to evaluate the SARS-CoV-2 severity. We found that most of the reported works based on deep learning focused on the detection of SARS-CoV-2 from medical images while the challenge for the radiologists is how to differentiate between SARS-CoV-2 and other viral infections with the same clinical features. Conclusion The identification of SARS-CoV-2 manifestations on medical images is a key step in radiological workflow for the diagnosis of the virus and could be useful for researchers working on computer-aided diagnosis of pulmonary infections.
- Published
- 2021
- Full Text
- View/download PDF
12. Pyloric adenomatous carcinoma of the gallbladder following laparoscopic cholecystectomy: A case report
- Author
-
Nao Kitasaki, Tomoyuki Abe, Masahiro Nakahara, Toshio Noriyuki, Keiji Hanada, and Akihiko Oshita
- Subjects
medicine.medical_specialty ,Adenoma ,medicine.medical_treatment ,Case Report ,HGM, human gastric mucin ,DL-DSS, deep learning-based decision support system ,CA19-9, carbohydrate antigen 19-9 ,medicine ,Gallbladder cancer ,Gallbladder Body ,MRCP, magnetic resonance cholangiopancreatography ,Magnetic resonance cholangiopancreatography ,medicine.diagnostic_test ,business.industry ,US, ultrasonography ,Gallbladder ,Incidental gallbladder cancer ,medicine.disease ,CT, computed tomography ,medicine.anatomical_structure ,GBC, gallbladder cancer ,Abdominal ultrasonography ,Cholecystectomy ,AI, artificial intelligence ,Laparoscopy ,Surgery ,Radiology ,CEA, carcinoembryonic antigen ,business ,EUS, endoscopic ultrasound ,Gallbladder Adenoma ,LC, laparoscopic cholecystectomy ,Gallbladder adenoma - Abstract
Introduction Adenoma and intra-adenoma carcinoma of the gallbladder are relatively rare diseases, and the World Health Organization classification reports a frequency of 0.3% for gallbladder adenomas. Precise preoperative diagnosis of gallbladder cancer, especially in the early stages, is challenging. Herein, we report a case of pyloric adenomatous carcinoma of the gallbladder, diagnosed by laparoscopic cholecystectomy and pathology, along with a literature review. This case was reported in accordance with the SCARE 2020 Guideline (Ref). Presentation of case A 62-year-old woman was diagnosed with a 4-mm polypoid lesion in the gallbladder during a medical examination. The patient was followed-up by ultrasonography (US) once a year and was referred to our department because of an increase in size. Carcinoembryonic antigen and carbohydrate antigen 19-9 levels were within normal limits. Abdominal ultrasonography revealed a pedunculated polypoid lesion in the body of the gallbladder measuring 8 mm. Computed tomography demonstrated that the whole tumor was enhanced in the early phase without significant lymph node enlargement. Magnetic resonance cholangiopancreatography demonstrated a type Ip polypoid lesion located in the body of the gallbladder without pancreaticobiliary junctional abnormalities. Endoscopic ultrasound detected a superficial nodular-type Ip polypoid lesion in the gallbladder body with a parenchyma-like internal echogenic pattern. Discussion Based on these findings, the patient was diagnosed with gallbladder adenoma, and laparoscopic cholecystectomy was performed. Histopathological examination revealed the tumor was a papillary growth of atypical high columnar epithelial cells. The final diagnosis was pyloric adenoma with high-grade dysplasia and intra-adenoma carcinoma. The patient is currently undergoing outpatient follow-up without recurrence for 1 year. Conclusion Early gallbladder carcinoma with adenoma should be considered in patients with small gallbladder polypoid lesions. Considering the surgical stress of cholecystectomy and the malignant potential of gallbladder cancer, preceding surgery would be acceptable., Highlights • Incidental gallbladder cancer is rare and preoperative assessment of GBPL is important. • Considering the malignant potential of GBC, preceding surgery would be acceptable.
- Published
- 2021
13. Virtual reality and artificial intelligence for 3-dimensional planning of lung segmentectomies
- Author
-
Alexander P.W.M. Maat, Anne-Marie C. Dingemans, Amir H Sadeghi, Edris A F Mahtab, Yannick J.H.J. Taverne, Ad J.J.C. Bogers, Robin Cornelissen, Cardiothoracic Surgery, and Pulmonary Medicine
- Subjects
Pulmonary and Respiratory Medicine ,medicine.medical_specialty ,medicine.medical_treatment ,Computed tomography ,Virtual reality ,Surgical planning ,S, segment ,Benign pathology ,SDG 3 - Good Health and Well-being ,NSCLC, non–small cell lung cancer ,Thoracic Oncology ,DICOM, digital imaging and communication in medicine ,medicine ,2D, 2 dimensional ,VR, virtual reality ,segmentectomy ,Preoperative planning ,medicine.diagnostic_test ,business.industry ,VATS, video assisted thoracoscopic surgery ,video-assisted thoracoscopic surgery ,3D, 3 dimensional ,CT, computed tomography ,lung cancer ,preoperative planning ,Thoracic: Lung Cancer: Evolving Technology ,Cardiothoracic surgery ,Video-assisted thoracoscopic surgery ,virtual reality ,Surgery ,AI, artificial intelligence ,Artificial intelligence ,business - Abstract
Background There has been an increasing trend toward pulmonary segmentectomies to treat early-stage lung cancer, small intrapulmonary metastases, and localized benign pathology. A complete preoperative understanding of pulmonary anatomy is essential for accurate surgical planning and case selection. Identifying intersegmental divisions is extremely difficult when performed on computed tomography. For the preoperative planning of segmentectomies, virtual reality (VR) and artificial intelligence could allow 3-dimensional visualization of the complex anatomy of pulmonary segmental divisions, vascular arborization, and bronchial anatomy. This technology can be applied by surgeons preoperatively to gain better insight into a patient's anatomy for planning segmentectomy. Methods In this prospective observational pilot study, we aim to assess and demonstrate the technical feasibility and clinical applicability of the first dedicated artificial intelligence-based and immersive 3-dimensional-VR platform (PulmoVR; jointly developed and manufactured by Department of Cardiothoracic Surgery [Erasmus Medical Center, Rotterdam, The Netherlands], MedicalVR [Amsterdam, The Netherlands], EVOCS Medical Image Communication [Fysicon BV, Oss, The Netherlands], and Thirona [Nijmegen, The Netherlands]) for preoperative planning of video-assisted thoracoscopic segmentectomies. Results A total of 10 eligible patients for segmentectomy were included in this study after referral through the institutional thoracic oncology multidisciplinary team. PulmoVR was successfully applied as a supplementary imaging tool to perform video-assisted thoracoscopic segmentectomies. In 40% of the cases, the surgical strategy was adjusted due to the 3-dimensional-VR–based evaluation of anatomy. This underlines the potential benefit of additional VR-guided planning of segmentectomy for both surgeon and patient. Conclusions Our study demonstrates the successful development and clinical application of the first dedicated artificial intelligence and VR platform for the planning of pulmonary segmentectomy. This is the first study that shows an immersive virtual reality-based application for preoperative planning of segmentectomy to the best of our knowledge., Graphical abstract The identification of segmental anatomy for surgical planning of lung segmentectomy is quite challenging with conventional imaging. In the current study, a novel method is presented to create artificial intelligence based virtual reality reconstructions to prepare for thoracoscopic segmentectomies in 10 consecutive patients. VR, Virtual reality; CT, computed tomography.
- Published
- 2021
14. Quantification of COVID-19 Opacities on Chest CT – Evaluation of a Fully Automatic AI-approach to Noninvasively Differentiate Critical Versus Noncritical Patients
- Author
-
Simon S. Martin, Simon Bernatz, Andreas M. Bucher, L Basten, Sabine Michalik, Thomas J. Vogl, Christian Booz, Christoph Mader, Moritz H. Albrecht, Vitali Koch, Leon D. Grünewald, and Scherwin Mahmoudi
- Subjects
PHO, Percentage of high opacity ,GTP, Alanine aminotransferase ,HR-CT, High-resolution computer tomography ,HST, Urea ,030218 nuclear medicine & medical imaging ,law.invention ,0302 clinical medicine ,DDI, D-dimers ,law ,LEU, White blood cell count ,Viral ,DI2IN, Deep Image to Image Network ,Lung ,Original Investigation ,COVID-19, Coronavirus disease 2019 ,Predictive marker ,biology ,RT-PCR, Real-time reverse transcription polymerase-chain-reaction ,Middle Aged ,Intensive care unit ,PCT, Procalcitonin ,ICU, Intensive care unit ,medicine.anatomical_structure ,030220 oncology & carcinogenesis ,Cohort ,Absolute neutrophil count ,CRP, C-reactive protein ,CT, Computed tomography ,LAC, Lactate ,LYM, Lymphocyte count ,RIS, Radiology information system ,TNTHS, Troponin ,HU, Hounsfield units ,SARS-CoV-2, Severe acute respiratory syndrome coronavirus type ,WHO, World Health Organization ,03 medical and health sciences ,Artificial Intelligence ,PACS, Picture archiving and communication system ,ARDS, Acute respiratory distress syndrome ,medicine ,Humans ,Radiology, Nuclear Medicine and imaging ,TPZ, Quick value ,DICOM, Digital Imaging and Communications in Medicine ,IL-6, Interleukin-6 ,THR, Thrombocyte count ,Retrospective Studies ,LDH, Lactate dehydrogenase ,business.industry ,VRT, Volume rendering technique ,SARS-CoV-2 infection ,AI, Artificial intelligence ,KREA, Creatinine ,GGO, Ground-glass opacities ,COVID-19 ,Retrospective cohort study ,Pneumonia ,medicine.disease ,Troponin ,Chest-CT ,BIL, Bilirubin ,biology.protein ,NEU, Neutrophil count ,Nuclear medicine ,business ,Tomography, X-Ray Computed - Abstract
OBJECTIVES: To evaluate the potential of a fully automatic artificial intelligence (AI)-driven computed tomography (CT) software prototype to quantify severity of COVID-19 infection on chest CT in relationship with clinical and laboratory data. METHODS: We retrospectively analyzed 50 patients with laboratory confirmed COVID-19 infection who had received chest CT between March and July 2020. Pulmonary opacifications were automatically evaluated by an AI-driven software and correlated with clinical and laboratory parameters using Spearman-Rho and linear regression analysis. We divided the patients into sub cohorts with or without necessity of intensive care unit (ICU) treatment. Sub cohort differences were evaluated employing Wilcoxon-Mann-Whitney-Test. RESULTS: We included 50 CT examinations (mean age, 57.24 years), of whom 24 (48%) had an ICU stay. Extent of COVID-19 like opacities on chest CT showed correlations (all p < 0.001 if not otherwise stated) with occurrence of ICU stay (Râ¯=â¯0.74), length of ICU stay (Râ¯=â¯0.81), lethal outcome (Râ¯=â¯0.56) and length of hospital stay (Râ¯=â¯0.33, p < 0.05). The opacities extent was correlated with laboratory parameters: neutrophil count (NEU) (Râ¯=â¯0.60), lactate dehydrogenase (LDH) (Râ¯=â¯0.60), troponin (TNTHS) (Râ¯=â¯0.55) and c-reactive protein (CRP) (Râ¯=â¯0.51). Differences (p < 0.001) between ICU group and non-ICU group concerned longer length of hospital stay (24.04 vs. 10.92 days), higher opacity score (12.50 vs. 4.96) and severity of laboratory data changes such as c-reactive protein (11.64 vs. 5.07 mg/dl, p < 0.01). CONCLUSIONS: Automatically AI-driven quantification of opacities on chest CT correlates with laboratory and clinical data in patients with confirmed COVID-19 infection and may serve as non-invasive predictive marker for clinical course of COVID-19.
- Published
- 2021
15. Radiology indispensable for tracking COVID-19
- Author
-
Jingwen Li, Xi Long, Xuefei Lv, Shaoping Hu, Xinyi Wang, Zhicheng Lin, Fang Fang, Nian Xiong, Yu Sun, and Dandan Zhang
- Subjects
Male ,Artificial intelligence ,SARS, Severe acute respiratory syndrome ,MRI, Magnetic resonance imaging ,Review ,030218 nuclear medicine & medical imaging ,HRCT, High-resolution CT ,0302 clinical medicine ,Pregnancy ,Risk Factors ,Mass Screening ,PET/CT, Positron emission computed tomography ,Stage (cooking) ,Child ,Tomography ,medicine.diagnostic_test ,Radiological and Ultrasound Technology ,General Medicine ,Positron emission tomography computed tomography ,Radiology Nuclear Medicine and imaging ,030220 oncology & carcinogenesis ,Radiological weapon ,CT, Computed tomography ,Female ,Radiology ,medicine.medical_specialty ,Patient Identification Systems ,Isolation (health care) ,Coronavirus disease 2019 (COVID-19) ,Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) ,X-ray computed ,Thoracic Imaging ,03 medical and health sciences ,Magnetic resonance imaging ,UTE, Ultrashort echo-time ,GGO, Ground-glass opacity ,medicine ,COVID-19, Novel coronavirus disease 2019 ,Humans ,Radiology, Nuclear Medicine and imaging ,RT-PCR, Reverse transcription-polymerase chain reaction ,business.industry ,AI, Artificial intelligence ,COVID-19 ,Gold standard (test) ,medicine.disease ,Pneumonia ,Early Diagnosis ,Positron-Emission Tomography ,business ,Tomography, X-Ray Computed ,18F-FDG, β-2-[18 F]-Fluoro-2-deoxy-D-glucose - Abstract
Highlights • Currently, chest computed tomography is recommended as the first-line imaging test for detecting COVID-19 pneumonia. • The most typical CT imaging finding of COVID-19 patients is ground-glass opacity, combined with reticular and/or interlobular septal thickening and consolidation. • CT is useful for monitoring patients with COVID-19, identifying associated vascular abnormalities and making differential diagnosis., With the rapid spread of COVID-19 worldwide, early detection and efficient isolation of suspected patients are especially important to prevent the transmission. Although nucleic acid testing of SARS-CoV-2 is still the gold standard for diagnosis, there are well-recognized early-detection problems including time-consuming in the diagnosis process, noticeable false-negative rate in the early stage and lacking nucleic acid testing kits in some areas. Therefore, effective and rational applications of imaging technologies are critical in aiding the screen and helping the diagnosis of suspected patients. Currently, chest computed tomography is recommended as the first-line imaging test for detecting COVID-19 pneumonia, which could allow not only early detection of the typical chest manifestations, but also timely estimation of the disease severity and therapeutic effects. In addition, other radiological methods including chest X-ray, magnetic resonance imaging, and positron emission computed tomography also show significant advantages in the detection of COVID-19 pneumonia. This review summarizes the applications of radiology and nuclear medicine in detecting and diagnosing COVID-19. It highlights the importance for these technologies to curb the rapid transmission during the pandemic, considering findings from special groups such as children and pregnant women.
- Published
- 2021
- Full Text
- View/download PDF
16. Multi-Radiologist User Study for Artificial Intelligence-Guided Grading of COVID-19 Lung Disease Severity on Chest Radiographs
- Author
-
Jo-Anne O. Shepard, Michael H. Lev, Marc D. Succi, Brent P. Little, Tarik K. Alkasab, Jayashree Kalpathy-Cramer, Matthew D. Li, and Dexter P. Mendoza
- Subjects
medicine.medical_specialty ,Artificial intelligence ,Computer-assisted diagnosis ,medicine.medical_treatment ,Radiography ,education ,Fleiss' kappa ,Severity of Illness Index ,030218 nuclear medicine & medical imaging ,03 medical and health sciences ,0302 clinical medicine ,Radiologists ,Severity of illness ,medicine ,Humans ,Intubation ,Radiology, Nuclear Medicine and imaging ,Lung ,PXS, Pulmonary x-ray severity ,Retrospective Studies ,COVID-19, Coronavirus disease 2019 ,medicine.diagnostic_test ,SARS-CoV-2 ,business.industry ,CXR, Chest x-ray ,AI, Artificial intelligence ,COVID-19 ,Retrospective cohort study ,Exact test ,Inter-rater reliability ,Chest radiograph ,Radiology Nuclear Medicine and imaging ,030220 oncology & carcinogenesis ,Preliminary Investigation ,Radiography, Thoracic ,Radiology ,business - Abstract
Rationale and Objectives Radiographic findings of COVID-19 pneumonia can be used for patient risk stratification; however, radiologist reporting of disease severity is inconsistent on chest radiographs (CXRs). We aimed to see if an artificial intelligence (AI) system could help improve radiologist interrater agreement. Materials and Methods We performed a retrospective multi-radiologist user study to evaluate the impact of an AI system, the PXS score model, on the grading of categorical COVID-19 lung disease severity on 154 chest radiographs into four ordinal grades (normal/minimal, mild, moderate, and severe). Four radiologists (two thoracic and two emergency radiologists) independently interpreted 154 CXRs from 154 unique patients with COVID-19 hospitalized at a large academic center, before and after using the AI system (median washout time interval was 16 days). Three different thoracic radiologists assessed the same 154 CXRs using an updated version of the AI system trained on more imaging data. Radiologist interrater agreement was evaluated using Cohen and Fleiss kappa where appropriate. The lung disease severity categories were associated with clinical outcomes using a previously published outcomes dataset using Fisher's exact test and Chi-square test for trend. Results Use of the AI system improved radiologist interrater agreement (Fleiss κ = 0.40 to 0.66, before and after use of the system). The Fleiss κ for three radiologists using the updated AI system was 0.74. Severity categories were significantly associated with subsequent intubation or death within 3 days. Conclusion An AI system used at the time of CXR study interpretation can improve the interrater agreement of radiologists.
- Published
- 2021
17. Role of deep learning in early detection of COVID-19: Scoping review
- Author
-
Haider Dhia Zubaydi, Mahmood Saleh Alzubaidi, Alaa Abd-Alrazaq, Ali Abdulqader Bin-Salem, Mowafa Househ, and Arfan Ahmed
- Subjects
CNN, Convolutional neural network ,Coronavirus disease 2019 (COVID-19) ,Computer science ,Computer applications to medicine. Medical informatics ,R858-859.7 ,Convolutional neural network ,Article ,WHO, World Health Organization ,Domain (software engineering) ,COVID-19, Corona Virus 2019 ,Health care ,Machine learning ,business.industry ,AI, Artificial intelligence ,DL, Deep Learning ,Deep learning ,ULS, Ultrasonography ,CXR, Chest X-Ray radiography ,COVID-19 ,CT, Computed Tomography ,Data science ,Coronavirus ,RNN, Recurrent Neural Network ,SARS-CoV-2, Severe Acute Respiratory Syndrome Coronavirus 2 ,Data extraction ,Scale (social sciences) ,Artificial intelligence ,business ,Transfer of learning ,General Economics, Econometrics and Finance - Abstract
Background Since the onset of the COVID-19 pandemic, the world witnessed disruption on an unprecedented scale affecting our daily lives including but not limited to healthcare, business, education, and transportation. Deep Learning (DL) is a branch of Artificial intelligence (AI) applications, the recent growth of DL includes features that could be helpful in fighting the COVID-19 pandemic. Utilizing such features could support public health efforts. Objective Investigate the literature available in the use of DL technology to support dealing with the COVID-19 crisis. We summarize the literature that uses DL features to analyze datasets for the purpose of a quick COVID-19 detection. Methods This review follows PRISMA Extension for Scoping Reviews (PRISMA-ScR). We have scanned the most two commonly used databases (IEEE, ACM). Search terms were identified based on the target intervention (DL) and the target population (COVID-19). Two authors independently handled study selection and one author assigned for data extraction. A narrative approach is used to synthesize the extracted data. Results We retrieved 53 studies and after passing through PRISMA excluding criteria, only 17 studies are considered in this review. All studies used deep learning for detection of COVID-19 cases in early stage based on different diagnostic modalities. Convolutional Neural Network (CNN) and Transfer Learning (TL) were the most commonly used techniques. Conclusion The included studies showed that DL techniques has significant impact on early detection of COVID-19 with high accuracy rate. However, most of the proposed methods are still in development and not tested in a clinical setting. Further investigation and collaboration are required from the research community and healthcare professionals in order to develop and standardize guidelines for use of DL in the healthcare domain.
- Published
- 2021
18. Dual energy imaging in cardiothoracic pathologies: A primer for radiologists and clinicians
- Author
-
Robert C. Gilkeson, Kaustav Bera, Elias Kikano, Simon Lennartz, Sachin S Saboo, Dhiraj Baruah, Amit Gupta, Ali Gholamrezanezhad, Nils Große Hokamp, and Kai Roman Laukamp
- Subjects
medicine.medical_specialty ,PCD, photon-counting detector ,Radiography ,R895-920 ,VMI, virtual mono-energetic images ,Single-photon emission computed tomography ,Article ,PET, positron emission tomography ,SVC, superior vena cava ,030218 nuclear medicine & medical imaging ,DECT, dual-energy computed tomography ,03 medical and health sciences ,Medical physics. Medical radiology. Nuclear medicine ,0302 clinical medicine ,Picture archiving and communication system ,VNC, virtual non-contrast images ,BT, blalock-taussig ,Dual energy CT ,medicine ,Dual energy radiography ,Radiology, Nuclear Medicine and imaging ,Computed radiography ,PACS, picture archiving and communication system ,medicine.diagnostic_test ,business.industry ,Photoelectric effect ,SNR, signal to noise ratio ,DESR, dual-energy subtraction radiography ,eGFR, estimated glomerular filtration rate ,Subtraction ,Digital Enhanced Cordless Telecommunications ,Dual-Energy Computed Tomography ,CR, computed radiography ,TNC, true non contrast ,NIH, national institute of health ,CAD, computer-aided detection ,PPV, positive predictive value ,NPV, negative predictive value ,Positron emission tomography ,030220 oncology & carcinogenesis ,SPECT, single photon emission computed tomography ,TAVI, transcatheter aortic valve implantation ,AI, artificial intelligence ,Radiology ,keV, kilo electron volt ,business ,kV, kilo volt - Abstract
Recent advances in dual-energy imaging techniques, dual-energy subtraction radiography (DESR) and dual-energy CT (DECT), offer new and useful additional information to conventional imaging, thus improving assessment of cardiothoracic abnormalities. DESR facilitates detection and characterization of pulmonary nodules. Other advantages of DESR include better depiction of pleural, lung parenchymal, airway and chest wall abnormalities, detection of foreign bodies and indwelling devices, improved visualization of cardiac and coronary artery calcifications helping in risk stratification of coronary artery disease, and diagnosing conditions like constrictive pericarditis and valvular stenosis. Commercially available DECT approaches are classified into emission based (dual rotation/spin, dual source, rapid kilovoltage switching and split beam) and detector-based (dual layer) systems. DECT provide several specialized image reconstructions. Virtual non-contrast images (VNC) allow for radiation dose reduction by obviating need for true non contrast images, low energy virtual mono-energetic images (VMI) boost contrast enhancement and help in salvaging otherwise non-diagnostic vascular studies, high energy VMI reduce beam hardening artifacts from metallic hardware or dense contrast material, and iodine density images allow quantitative and qualitative assessment of enhancement/iodine distribution. The large amount of data generated by DECT can affect interpreting physician efficiency but also limit clinical adoption of the technology. Optimization of the existing workflow and streamlining the integration between post-processing software and picture archiving and communication system (PACS) is therefore warranted.
- Published
- 2021
19. Artificial intelligence-based computer-aided diagnosis system supports diagnosis of lymph node metastasis in esophageal squamous cell carcinoma: A multicenter study.
- Author
-
Zhang ST, Wang SY, Zhang J, Dong D, Mu W, Xia XE, Fu FF, Lu YN, Wang S, Tang ZC, Li P, Qu JR, Wang MY, Tian J, and Liu JH
- Abstract
Background: This study aimed to develop an artificial intelligence-based computer-aided diagnosis system (AI-CAD) emulating the diagnostic logic of radiologists for lymph node metastasis (LNM) in esophageal squamous cell carcinoma (ESCC) patients, which contributed to clinical treatment decision-making., Methods: A total of 689 ESCC patients with PET/CT images were enrolled from three hospitals and divided into a training cohort and two external validation cohorts. 452 CT images from three publicly available datasets were also included for pretraining the model. Anatomic information from CT images was first obtained automatically using a U-Net-based multi-organ segmentation model, and metabolic information from PET images was subsequently extracted using a gradient-based approach. AI-CAD was developed in the training cohort and externally validated in two validation cohorts., Results: The AI-CAD achieved an accuracy of 0.744 for predicting pathological LNM in the external cohort and a good agreement with a human expert in two external validation cohorts (kappa = 0.674 and 0.587, p < 0.001). With the aid of AI-CAD, the human expert's diagnostic performance for LNM was significantly improved (accuracy [95% confidence interval]: 0.712 [0.669-0.758] vs. 0.833 [0.797-0.865], specificity [95% confidence interval]: 0.697 [0.636-0.753] vs. 0.891 [0.851-0.928]; p < 0.001) among patients underwent lymphadenectomy in the external validation cohorts., Conclusions: The AI-CAD could aid in preoperative diagnosis of LNM in ESCC patients and thereby support clinical treatment decision-making., Competing Interests: The authors declare no competing interests., (© 2023 The Authors.)
- Published
- 2023
- Full Text
- View/download PDF
20. Automated pancreatic islet viability assessment for transplantation using bright-field deep morphological signature.
- Author
-
Habibalahi A, Campbell JM, Walters SN, Mahbub SB, Anwer AG, Grey ST, and Goldys EM
- Abstract
Islets transplanted for type-1 diabetes have their viability reduced by warm ischemia, dimethyloxalylglycine (DMOG; hypoxia model), oxidative stress and cytokine injury. This results in frequent transplant failures and the major burden of patients having to undergo multiple rounds of treatment for insulin independence. Presently there is no reliable measure to assess islet preparation viability prior to clinical transplantation. We investigated deep morphological signatures (DMS) for detecting the exposure of islets to viability compromising insults from brightfield images. Accuracies ranged from 98 % to 68 % for; ROS damage, pro-inflammatory cytokines, warm ischemia and DMOG. When islets were disaggregated to single cells to enable higher throughput data collection, good accuracy was still obtained (83-71 %). Encapsulation of islets reduced accuracy for cytokine exposure, but it was still high (78 %). Unsupervised modelling of the DMS for islet preparations transplanted into a syngeneic mouse model was able to predict whether or not they would restore glucose control with 100 % accuracy. Our strategy for constructing DMS' is effective for the assessment of islet pre-transplant viability. If translated into the clinic, standard equipment could be used to prospectively identify non-functional islet preparations unable to contribute to the restoration of glucose control and reduce the burden of unsuccessful treatments., Competing Interests: No conflict of interest., (© 2023 The Authors.)
- Published
- 2023
- Full Text
- View/download PDF
21. Algorithms for automated diagnosis of cardiovascular diseases based on ECG data: A comprehensive systematic review.
- Author
-
Denysyuk HV, Pinto RJ, Silva PM, Duarte RP, Marinho FA, Pimenta L, Gouveia AJ, Gonçalves NJ, Coelho PJ, Zdravevski E, Lameski P, Leithardt V, Garcia NM, and Pires IM
- Abstract
The prevalence of cardiovascular diseases is increasing around the world. However, the technology is evolving and can be monitored with low-cost sensors anywhere at any time. This subject is being researched, and different methods can automatically identify these diseases, helping patients and healthcare professionals with the treatments. This paper presents a systematic review of disease identification, classification, and recognition with ECG sensors. The review was focused on studies published between 2017 and 2022 in different scientific databases, including PubMed Central, Springer, Elsevier, Multidisciplinary Digital Publishing Institute (MDPI), IEEE Xplore, and Frontiers. It results in the quantitative and qualitative analysis of 103 scientific papers. The study demonstrated that different datasets are available online with data related to various diseases. Several ML/DP-based models were identified in the research, where Convolutional Neural Network and Support Vector Machine were the most applied algorithms. This review can allow us to identify the techniques that can be used in a system that promotes the patient's autonomy., Competing Interests: The authors declare no competing interests., (© 2023 The Authors.)
- Published
- 2023
- Full Text
- View/download PDF
22. Development of a tongue image-based machine learning tool for the diagnosis of gastric cancer: a prospective multicentre clinical cohort study.
- Author
-
Yuan L, Yang L, Zhang S, Xu Z, Qin J, Shi Y, Yu P, Wang Y, Bao Z, Xia Y, Sun J, He W, Chen T, Chen X, Hu C, Zhang Y, Dong C, Zhao P, Wang Y, Jiang N, Lv B, Xue Y, Jiao B, Gao H, Chai K, Li J, Wang H, Wang X, Guan X, Liu X, Zhao G, Zheng Z, Yan J, Yu H, Chen L, Ye Z, You H, Bao Y, Cheng X, Zhao P, Wang L, Zeng W, Tian Y, Chen M, You Y, Yuan G, Ruan H, Gao X, Xu J, Xu H, Du L, Zhang S, Fu H, and Cheng X
- Abstract
Background: Tongue images (the colour, size and shape of the tongue and the colour, thickness and moisture content of the tongue coating), reflecting the health state of the whole body according to the theory of traditional Chinese medicine (TCM), have been widely used in China for thousands of years. Herein, we investigated the value of tongue images and the tongue coating microbiome in the diagnosis of gastric cancer (GC)., Methods: From May 2020 to January 2021, we simultaneously collected tongue images and tongue coating samples from 328 patients with GC (all newly diagnosed with GC) and 304 non-gastric cancer (NGC) participants in China, and 16 S rDNA was used to characterize the microbiome of the tongue coating samples. Then, artificial intelligence (AI) deep learning models were established to evaluate the value of tongue images and the tongue coating microbiome in the diagnosis of GC. Considering that tongue imaging is more convenient and economical as a diagnostic tool, we further conducted a prospective multicentre clinical study from May 2020 to March 2022 in China and recruited 937 patients with GC and 1911 participants with NGC from 10 centres across China to further evaluate the role of tongue images in the diagnosis of GC. Moreover, we verified this approach in another independent external validation cohort that included 294 patients with GC and 521 participants with NGC from 7 centres. This study is registered at ClinicalTrials.gov, NCT01090362., Findings: For the first time, we found that both tongue images and the tongue coating microbiome can be used as tools for the diagnosis of GC, and the area under the curve (AUC) value of the tongue image-based diagnostic model was 0.89. The AUC values of the tongue coating microbiome-based model reached 0.94 using genus data and 0.95 using species data. The results of the prospective multicentre clinical study showed that the AUC values of the three tongue image-based models for GCs reached 0.88-0.92 in the internal verification and 0.83-0.88 in the independent external verification, which were significantly superior to the combination of eight blood biomarkers., Interpretation: Our results suggest that tongue images can be used as a stable method for GC diagnosis and are significantly superior to conventional blood biomarkers. The three kinds of tongue image-based AI deep learning diagnostic models that we developed can be used to adequately distinguish patients with GC from participants with NGC, even early GC and precancerous lesions, such as atrophic gastritis (AG)., Funding: The National Key R&D Program of China (2021YFA0910100), Program of Zhejiang Provincial TCM Sci-tech Plan (2018ZY006), Medical Science and Technology Project of Zhejiang Province (2022KY114, WKJ-ZJ-2104), Zhejiang Provincial Research Center for Upper Gastrointestinal Tract Cancer (JBZX-202006), Natural Science Foundation of Zhejiang Province (HDMY22H160008), Science and Technology Projects of Zhejiang Province (2019C03049), National Natural Science Foundation of China (82074245, 81973634, 82204828), and Chinese Postdoctoral Science Foundation (2022M713203)., Competing Interests: All authors declare no competing interests., (© 2023 The Author(s).)
- Published
- 2023
- Full Text
- View/download PDF
23. Artificial intelligence to predict outcomes of head and neck radiotherapy.
- Author
-
Bang C, Bernard G, Le WT, Lalonde A, Kadoury S, and Bahig H
- Abstract
Head and neck radiotherapy induces important toxicity, and its efficacy and tolerance vary widely across patients. Advancements in radiotherapy delivery techniques, along with the increased quality and frequency of image guidance, offer a unique opportunity to individualize radiotherapy based on imaging biomarkers, with the aim of improving radiation efficacy while reducing its toxicity. Various artificial intelligence models integrating clinical data and radiomics have shown encouraging results for toxicity and cancer control outcomes prediction in head and neck cancer radiotherapy. Clinical implementation of these models could lead to individualized risk-based therapeutic decision making, but the reliability of the current studies is limited. Understanding, validating and expanding these models to larger multi-institutional data sets and testing them in the context of clinical trials is needed to ensure safe clinical implementation. This review summarizes the current state of the art of machine learning models for prediction of head and neck cancer radiotherapy outcomes., Competing Interests: The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper., (© 2023 The Authors.)
- Published
- 2023
- Full Text
- View/download PDF
24. The applications of machine learning to predict the forming of chemically stable amorphous solid dispersions prepared by hot-melt extrusion.
- Author
-
Jiang J, Lu A, Ma X, Ouyang D, and Williams RO 3rd
- Abstract
Amorphous solid dispersion (ASD) is one of the most important strategies to improve the solubility and dissolution rate of poorly water-soluble drugs. As a widely used technique to prepare ASDs, hot-melt extrusion (HME) provides various benefits, including a solvent-free process, continuous manufacturing, and efficient mixing compared to solvent-based methods, such as spray drying. Energy input, consisting of thermal and specific mechanical energy, should be carefully controlled during the HME process to prevent chemical degradation and residual crystallinity. However, a conventional ASD development process uses a trial-and-error approach, which is laborious and time-consuming. In this study, we have successfully built multiple machine learning (ML) models to predict the amorphization of crystalline drug formulations and the chemical stability of subsequent ASDs prepared by the HME process. We utilized 760 formulations containing 49 active pharmaceutical ingredients (APIs) and multiple types of excipients. By evaluating the built ML models, we found that ECFP-LightGBM was the best model to predict amorphization with an accuracy of 92.8%. Furthermore, ECFP-XGBoost was the best in estimating chemical stability with an accuracy of 96.0%. In addition, the feature importance analyses based on SHapley Additive exPlanations (SHAP) and information gain (IG) revealed that several processing parameters and material attributes (i.e., drug loading, polymer ratio, drug's Extended-connectivity fingerprints (ECFP) fingerprints, and polymer's properties) are critical for achieving accurate predictions for the selected models. Moreover, important API's substructures related to amorphization and chemical stability were determined, and the results are largely consistent with the literature. In conclusion, we established the ML models to predict formation of chemically stable ASDs and identify the critical attributes during HME processing. Importantly, the developed ML methodology has the potential to facilitate the product development of ASDs manufactured by HME with a much reduced human workload., Competing Interests: The authors declare no financial interests/personal relationships that may be considered as potential competing interests., (© 2023 The Authors.)
- Published
- 2023
- Full Text
- View/download PDF
25. Deep learning-based automatic left atrial appendage filling defects assessment on cardiac computed tomography for clinical and subclinical atrial fibrillation patients.
- Author
-
Chen L, Huang SH, Wang TH, Lan TY, Tseng VS, Tsao HM, Wang HH, and Tang GJ
- Abstract
Rationale and Objectives: Selecting region of interest (ROI) for left atrial appendage (LAA) filling defects assessment can be time consuming and prone to subjectivity. This study aimed to develop and validate a novel artificial intelligence (AI), deep learning (DL) based framework for automatic filling defects assessment on CT images for clinical and subclinical atrial fibrillation (AF) patients., Materials and Methods: A total of 443,053 CT images were used for DL model development and testing. Images were analyzed by the AI framework and expert cardiologists/radiologists. The LAA segmentation performance was evaluated using Dice coefficient. The agreement between manual and automatic LAA ROI selections was evaluated using intraclass correlation coefficient (ICC) analysis. Receiver operating characteristic (ROC) curve analysis was used to assess filling defects based on the computed LAA to ascending aorta Hounsfield unit (HU) ratios., Results: A total of 210 patients (Group 1: subclinical AF, n = 105; Group 2: clinical AF with stroke, n = 35; Group 3: AF for catheter ablation, n = 70) were enrolled. The LAA volume segmentation achieved 0.931-0.945 Dice scores. The LAA ROI selection demonstrated excellent agreement (ICC ≥0.895, p < 0.001) with manual selection on the test sets. The automatic framework achieved an excellent AUC score of 0.979 in filling defects assessment. The ROC-derived optimal HU ratio threshold for filling defects detection was 0.561., Conclusion: The novel AI-based framework could accurately segment the LAA region and select ROIs while effectively avoiding trabeculae for filling defects assessment, achieving close-to-expert performance. This technique may help preemptively detect the potential thromboembolic risk for AF patients., Competing Interests: The authors declare no competing interests., (© 2023 The Authors.)
- Published
- 2023
- Full Text
- View/download PDF
26. Personalized predictions of adverse side effects of the COVID-19 vaccines.
- Author
-
Jamshidi E, Asgary A, Kharrazi AY, Tavakoli N, Zali A, Mehrazi M, Jamshidi M, Farrokhi B, Maher A, von Garnier C, Rahi SJ, and Mansouri N
- Abstract
Background: Misconceptions about adverse side effects are thought to influence public acceptance of the Coronavirus disease 2019 (COVID-19) vaccines negatively. To address such perceived disadvantages of vaccines, a novel machine learning (ML) approach was designed to generate personalized predictions of the most common adverse side effects following injection of six different COVID-19 vaccines based on personal and health-related characteristics., Methods: Prospective data of adverse side effects following COVID-19 vaccination in 19943 participants from Iran and Switzerland was utilized. Six vaccines were studied: The AZD1222, Sputnik V, BBIBP-CorV, COVAXIN, BNT162b2, and the mRNA-1273 vaccine. The eight side effects were considered as the model output: fever, fatigue, headache, nausea, chills, joint pain, muscle pain, and injection site reactions. The total input parameters for the first and second dose predictions were 46 and 54 features, respectively, including age, gender, lifestyle variables, and medical history. The performances of multiple ML models were compared using Area Under the Receiver Operating Characteristic Curve (ROC-AUC)., Results: The total number of people receiving the first dose of the AZD1222, Sputnik V, BBIBP-CorV, COVAXIN, BNT162b2, and mRNA-1273 were 6022, 7290, 5279, 802, 277, and 273, respectively. For the second dose, the numbers were 2851, 5587, 3841, 599, 242 and 228. The Logistic Regression model for predicting different side effects of the first dose achieved ROC-AUCs of 0.620-0.686, 0.685-0.716, 0.632-0.727, 0.527-0.598, 0.548-0.655, 0.545-0.712 for the AZD1222, Sputnik V, BBIBP-CorV, COVAXIN, BNT162b2 and mRNA-1273 vaccines, respectively. The second dose models yielded ROC-AUCs of 0.777-0.867, 0.795-0.848, 0.857-0.906, 0.788-0.875, 0.683-0.850, and 0.486-0.680, respectively., Conclusions: Using a large cohort of recipients vaccinated with COVID-19 vaccines, a novel and personalized strategy was established to predict the occurrence of the most common adverse side effects with high accuracy. This technique can serve as a tool to inform COVID-19 vaccine selection and generate personalized factsheets to curb concerns about adverse side effects., (© 2022 The Authors.)
- Published
- 2023
- Full Text
- View/download PDF
27. Artificial Intelligence in Hepatology- Ready for the Primetime.
- Author
-
Kalapala R, Rughwani H, and Reddy DN
- Abstract
Artificial Intelligence (AI) is a mathematical process of computer mediating designing of algorithms to support human intelligence. AI in hepatology has shown tremendous promise to plan appropriate management and hence improve treatment outcomes. The field of AI is in a very early phase with limited clinical use. AI tools such as machine learning, deep learning, and 'big data ' are in a continuous phase of evolution, presently being applied for clinical and basic research. In this review, we have summarized various AI applications in hepatology, the pitfalls and AI's future implications. Different AI models and algorithms are under study using clinical, laboratory, endoscopic and imaging parameters to diagnose and manage liver diseases and mass lesions. AI has helped to reduce human errors and improve treatment protocols. Further research and validation are required for future use of AI in hepatology., (© 2022 Indian National Association for Study of the Liver. Published by Elsevier B.V. All rights reserved.)
- Published
- 2023
- Full Text
- View/download PDF
28. Coronavirus Disease 2019 (COVID-19) diagnostic technologies: A country-based retrospective analysis of screening and containment procedures during the first wave of the pandemic
- Author
-
Brandon K.K. Fields, Ali Gholamrezanezhad, and Natalie L. Demirjian
- Subjects
Disease ,medicine.disease_cause ,Global Health ,Polymerase Chain Reaction ,US, United States ,030218 nuclear medicine & medical imaging ,0302 clinical medicine ,COVID-19 Testing ,Pandemic ,Global health ,Mass Screening ,Cardiothoracic Imaging ,Coronavirus ,CT, computed tomography ,Europe ,Radiology Nuclear Medicine and imaging ,030220 oncology & carcinogenesis ,COVID-19, Coronavirus Disease 2019 ,Workforce ,AI, artificial intelligence ,Coronavirus Infections ,Radiology ,medicine.medical_specialty ,Asia ,Middle East respiratory syndrome coronavirus ,Pneumonia, Viral ,RT-PCR ,WHO, World Health Organization ,03 medical and health sciences ,Betacoronavirus ,RT-PCR, reverse transcription polymerase chain reaction ,Chest CT ,medicine ,Humans ,Radiology, Nuclear Medicine and imaging ,Intensive care medicine ,Pandemics ,Machine-learning ,Retrospective Studies ,business.industry ,Clinical Laboratory Techniques ,SARS-CoV-2 ,COVID-19 ,Retrospective cohort study ,Pneumonia ,medicine.disease ,SARS-CoV-2, Severe Acute Respiratory Syndrome Coronavirus 2 ,Communicable Disease Control ,North America ,business ,Tomography, X-Ray Computed - Abstract
Since first report of a novel coronavirus in December of 2019, the Coronavirus Disease 2019 (COVID-19) pandemic has crippled healthcare systems around the world. While many initial screening protocols centered around laboratory detection of the virus, early testing assays were thought to be poorly sensitive in comparison to chest computed tomography, especially in asymptomatic disease. Coupled with shortages of reverse transcription polymerase chain reaction (RT-PCR) testing kits in many parts of the world, these regions instead turned to the use of advanced imaging as a first-line screening modality. However, in contrast to previous Severe Acute Respiratory Syndrome and Middle East Respiratory Syndrome coronavirus epidemics, chest X-ray has not demonstrated optimal sensitivity to be of much utility in first-line screening protocols. Though current national and international guidelines recommend for the use of RT-PCR as the primary screening tool for suspected cases of COVID-19, institutional and regional protocols must consider local availability of resources when issuing universal recommendations. Successful containment and social mitigation strategies worldwide have been thus far predicated on unified governmental responses, though the underlying ideologies of these practices may not be widely applicable in many Western nations. As the strain on the radiology workforce continues to mount, early results indicate a promising role for the use of machine-learning algorithms as risk stratification schema in the months to come., Highlights • Screening protocols must consider subspecialist expertise and time to diagnosis, in addition to diagnostic accuracy. • National and institutional protocols must further consider local availability of resources. • Machine-learning and artificial intelligence algorithms may come to play invaluable roles as risk stratification schema.
- Published
- 2020
- Full Text
- View/download PDF
29. New technologies and Amyotrophic Lateral Sclerosis – Which step forward rushed by the COVID-19 pandemic?
- Author
-
Susana Pinto, Vincenzo Silani, and Stefano Quintarelli
- Subjects
Artificial intelligence ,MIE, Mechanical insufflator-exsuflattor ,EQoL-5D, European quality of life questionnaire ,LL, Lower limb ,Disease ,AR, Augmented Reality ,Virtual reality ,Health Services Accessibility ,0302 clinical medicine ,BCI, Brain-computer interfaces ,Multidisciplinary approach ,ALS, Amyotrophic Lateral Sclerosis ,Respiratory function ,030212 general & internal medicine ,Amyotrophic lateral sclerosis ,UL, Upper limb ,GDPR, General Data Privacy Regulation ,NEALS, Northeast ALS Consortium ,VR, Virtual Reality ,Cognition ,Robotics ,Telemedicine ,Augmentative and alternative communication ,Neurology ,FVC, Forced vital capacity ,ML, Machine Learning ,Brain-computer interfaces ,Psychology ,AAC, Augmentative and alternative communication ,Emerging technologies ,ECAS, Edinburgh Cognitive and Behavioural ALS Screen ,NIV, Non-invasive ventilation ,Clinical Neurology ,MIP, Maximal inspiratory pressure ,Article ,PLS, Primary lateral sclerosis ,WHO, World Health Organization ,03 medical and health sciences ,QoL, Quality of life ,Inventions ,EU, European Union ,medicine ,Humans ,Pandemics ,Medical education ,AI, Artificial intelligence ,Amyotrophic Lateral Sclerosis ,COVID-19 ,ALSFRS-R, Revised ALS functional rating scale ,ADL, Activities of daily life ,HAD scale, Hospital Anxiety and Depression scale ,pt, patient ,medicine.disease ,ENCALS, European Network for the Cure of ALS ,ET, Eye tracking ,Neurology (clinical) ,Eye-tracking ,030217 neurology & neurosurgery - Abstract
Amyotrophic Lateral Sclerosis (ALS) is a fast-progressive neurodegenerative disease leading to progressive physical immobility with usually normal or mild cognitive and/or behavioural involvement. Many patients are relatively young, instructed, sensitive to new technologies, and professionally active when developing the first symptoms. Older patients usually require more time, encouragement, reinforcement and a closer support but, nevertheless, selecting user-friendly devices, provided earlier in the course of the disease, and engaging motivated carers may overcome many technological barriers. ALS may be considered a model for neurodegenerative diseases to further develop and test new technologies. From multidisciplinary teleconsults to telemonitoring of the respiratory function, telemedicine has the potentiality to embrace other fields, including nutrition, physical mobility, and the interaction with the environment. Brain-computer interfaces and eye tracking expanded the field of augmentative and alternative communication in ALS but their potentialities go beyond communication, to cognition and robotics. Virtual reality and different forms of artificial intelligence present further interesting possibilities that deserve to be investigated. COVID-19 pandemic is an unprecedented opportunity to speed up the development and implementation of new technologies in clinical practice, improving the daily living of both ALS patients and carers. The present work reviews the current technologies for ALS patients already in place or being under evaluation with published publications, prompted by the COVID-19 pandemic., Highlights • ALS is a model to further develop telemedicine and new technologies, being the COVID-19 pandemic an unexpected opportunity to speed up the process. • Telemedicine has already been successfully implemented in some ALS centres, being feasible, safe, with positive cost-benefit aspects. • New technologies especially projected to facilitate ALS patients and carers in communication, mobility, interaction and control of the environment, as well as cognitive assessment are ongoing and many already available • The control of the new technologies by telemedicine will further promote the care to ALS patients. • Legal issues deserve more attention in the near future.
- Published
- 2020
- Full Text
- View/download PDF
30. Reliability of multi-purpose offshore-facilities: Present status and future direction in Australia
- Author
-
Nagi Abdussamie, Al Amin Baksh, Allan Ross Magee, Roquzbeh Abbassi, Jonathan Abrahams, Mark Underwood, Mohsen Asadnia, Chien Ming Wang, Ang Kok Keng, Hassan Karampour, Fatemeh Salehi, Denham G. Cook, Chris Shearer, Scott Draper, Lim Kian Yew, Vikram Garaniya, Irene Penesis, Andrew Martini, Vahid Aryai, Kevin Heasman, and Suba Sivandran
- Subjects
EMA, Experimental Modal Analysis ,NOAA, USA National Oceanic and Atmospheric Administration ,PE, Polyethylene ,Computer science ,FOWT, Floating offshore wind turbine ,Blue economy ,General Chemical Engineering ,AUV, Autonomous underwater vehicles ,0211 other engineering and technologies ,02 engineering and technology ,HDPE, High-Density Polyethylene ,010501 environmental sciences ,FORM, First Order Reliability Method ,MPOP, Multi-Purpose Offshore-Platforms ,SHM, Structural health monitoring ,01 natural sciences ,Vertical integration ,CSRV, Common source random variables ,GIS, Geographic information system ,LS, Line Sampling ,MEMS, Microelectromechanical systems ,OREDA, Offshore and Onshore Reliability Data database ,WEC, Wave energy converter ,PVC, Polyvinyl Chloride ,QRS, Quantum Resistive Sensors ,Ocean multi-use ,SAFER ,EGRA, Efficient Global Reliability Analysis ,Safety, Risk, Reliability and Quality ,Reliability (statistics) ,NARMAX, Non-linear Auto-Regressive Moving Average with exogenous inputs model ,RSM, Response Surface Method ,MOB, Mobile offshore base ,ROV, Remotely operated vehicles ,PET, Polyethylene terephthalate ,FDD, Frequency Domain Decomposition ,SCADA, Supervisory Control and Data Acquisition ,Renewable energy ,WSE, Wave Swell Energy ,VLFS, Very large floating structure ,OWT, Offshore wind turbine ,Risk analysis (engineering) ,PES, Polyurethane polyester ,CBM, Condition-based monitoring ,MCS, Monte Carlo Simulation ,SS, Subset Simulation ,FMEA, Failure Mode and Effects Analysis ,GI, Galvanised iron ,IS, Importance Sampling ,MFS, Modular floating structures ,Environmental Engineering ,SES, Dragon and Seaweed Energy Solutions ,O&M, Operations and management ,SWAN, Simulating Waves Nearshore ,Article ,FBG, Fibre Bragg Grating ,FLNG, Floating Liquefied Natural Gas ,FPSO, Floating structures for production, storage and offloading ,LH, Latin Hypercube ,OMA, Operational Modal Analysis ,SORM, Second-Order Reliability Method ,Environmental Chemistry ,FE, Finite element ,0105 earth and related environmental sciences ,021110 strategic, defence & security studies ,Government ,Data collection ,AK-, Active Learning ,business.industry ,AI, Artificial intelligence ,PP, Polypropylene ,PSP, Pneumatically Stabilized Platform ,MCS, Reliability Method with integrated Kriging and MCS ,RAMS, Reliability, Availability, Maintainability, and Safety ,ARENA, Australian Renewable Energy Agency ,NWW3, NOAA Wave Watch III ,Structural integrity ,Offshore geotechnical engineering ,Sustainability ,CSIRO, Commonwealth Scientific and Industrial Research Organisation ,business ,Reliability analysis ,Offshore platforms - Abstract
Sustainable use of the ocean for food and energy production is an emerging area of research in different countries around the world. This goal is pursued by the Australian aquaculture, offshore engineering and renewable energy industries, research organisations and the government through the “Blue Economy Cooperative Research Centre”. To address the challenges of offshore food and energy production, leveraging the benefits of co-location, vertical integration, infrastructure and shared services, will be enabled through the development of novel Multi-Purpose Offshore-Platforms (MPOP). The structural integrity of the designed systems when being deployed in the harsh offshore environment is one of the main challenges in developing the MPOPs. Employing structural reliability analysis methods for assessing the structural safety of the novel aquaculture-MPOPs comes with different limitations. This review aims at shedding light on these limitations and discusses the current status and future directions for structural reliability analysis of a novel aquaculture-MPOP considering Australia’s unique environment. To achieve this aim, challenges which exist at different stages of reliability assessment, from data collection and uncertainty quantification to load and structural modelling and reliability analysis implementation, are discussed. Furthermore, several solutions to these challenges are proposed based on the existing knowledge in other sectors, and particularly from the offshore oil and gas industry. Based on the identified gaps in the review process, potential areas for future research are introduced to enable a safer and more reliable operation of the MPOPs.
- Published
- 2020
31. Biomarkers of COVID-19 and technologies to combat SARS-CoV-2
- Author
-
Luoping Zhang and Helen Guo
- Subjects
Emergency Use Authorization ,LFAs, Lateral flow assays ,SARS, Severe acute respiratory syndrome ,PAC-MAN, Prophylactic Antiviral CRISPR in huMAN cells ,NIH, National Institutes of Health ,Pandemic ,Diagnosis ,HCQ, Hydroxychloroquine ,CQ, Chloroquine ,AIOD-CRISPR, All-In-One Dual CRISPR-Cas12a ,COVID ,COVID-19, Coronavirus disease 2019 ,General Engineering ,Prognosis ,DC, Dendritic cell ,SaaS, Software as a Service ,PCT, Procalcitonin ,Detection ,UCB, University of California Berkeley ,ARB, Angiotensin receptor blocker ,ELISA, Enzyme-linked immunosorbent assay ,cDNA, Complementary DNA ,NIAID, U.S. National Institute of Allergy and Infectious Diseases ,Biomarker (medicine) ,CT, Computed tomography ,TCM, Traditional Chinese medicine ,ACEI, Angiotensin-converting enzyme inhibitor ,ML, Machine learning ,medicine.medical_specialty ,Coronavirus disease 2019 (COVID-19) ,Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) ,UCSF, University of California San Francisco ,Article ,EUA, Emergency use authorization ,ACE2, Angiotensin-converting enzyme 2 ,ARDS, Acute respiratory distress syndrome ,medicine ,Intensive care medicine ,Government ,business.industry ,Public health ,Prevention ,AI, Artificial intelligence ,MERS, Middle East respiratory syndrome ,SARS-CoV-2, SARS coronavirus type 2 ,GenOMICC, Genetics of Mortality in Critical Care ,RT-PCR, Reverse transcription polymerase chain reaction ,medicine.disease ,Coronavirus ,Treatment ,FDA, U.S. Food and Drug Administration ,LSPR, Localized surface plasmon resonance ,mAb, Monoclonal antibody ,Middle East respiratory syndrome ,PCR, Polymerase chain reaction ,business - Abstract
Due to the unprecedented public health crisis caused by COVID-19, our first contribution to the newly launching journal, Advances in Biomarker Sciences and Technology, has abruptly diverted to focus on the current pandemic. As the number of new COVID-19 cases and deaths continue to rise steadily around the world, the common goal of healthcare providers, scientists, and government officials worldwide has been to identify the best way to detect the novel coronavirus, named SARS-CoV-2, and to treat the viral infection – COVID-19. Accurate detection, timely diagnosis, effective treatment, and future prevention are the vital keys to management of COVID-19 and can help curb the viral spread. Traditionally, biomarkers play a pivotal role in the early detection of disease etiology, diagnosis, treatment and prognosis. To assist myriad ongoing investigations and innovations, we developed this current article that overviews known and emerging biomarkers for SARS-CoV-2 detection, COVID-19 diagnostics, treatment and prognosis, and ongoing work to identify and develop more biomarkers for new drugs and vaccines. Moreover, biomarkers of socio-psychological stress, the high-technology quest for new virtual drug screening, and digital applications are described.
- Published
- 2020
32. Quantitative approaches in clinical reproductive endocrinology.
- Author
-
Voliotis M, Hanassab S, Abbara A, Heinis T, Dhillo WS, and Tsaneva-Atanasova K
- Abstract
Understanding the human hypothalamic-pituitary-gonadal (HPG) axis presents a major challenge for medical science. Dysregulation of the HPG axis is linked to infertility and a thorough understanding of its dynamic behaviour is necessary to both aid diagnosis and to identify the most appropriate hormonal interventions. Here, we review how quantitative models are being used in the context of clinical reproductive endocrinology to: 1. analyse the secretory patterns of reproductive hormones; 2. evaluate the effect of drugs in fertility treatment; 3. aid in the personalization of assisted reproductive technology (ART). In this review, we demonstrate that quantitative models are indispensable tools enabling us to describe the complex dynamic behaviour of the reproductive axis, refine the treatment of fertility disorders, and predict clinical intervention outcomes., Competing Interests: Nothing declared., (© 2022 The Author(s).)
- Published
- 2022
- Full Text
- View/download PDF
33. How to avoid future "Covid-19 origins" questions?
- Author
-
Su Z, McDonnell D, Cheshmehzangi A, Ahmad J, Šegalo S, da Veiga CP, and Xiang YT
- Abstract
Origins debates regarding Covid-19 are gaining momentum again. In light of the continued infections and deaths of Covid-19 seen in countries rich and poor, rather than focusing the approach with "whodunit", developing solutions that can help societies become better prepared for future pandemics might be a more meaningful way to move forward. In this paper, we propose a solution that could help society better predict and prevent future pandemics. A system could allow humans to anonymously report potential infectious disease outbreaks without fearing backlash or prejudice and could automatically surveil for potential disease transfers or virus leaks. The proposed autonomous and anonymous pandemic reporting and surveillance system has the potential to help health officials locate infectious disease outbreaks before they form into pandemics. And in turn, it better prevents future pandemics and avoids Covid-19 origins debates., (© 2022 Elsevier Masson SAS. All rights reserved.)
- Published
- 2022
- Full Text
- View/download PDF
34. Radiomics-Based Assessment of OCT Angiography Images for Diabetic Retinopathy Diagnosis.
- Author
-
Carrera-Escalé L, Benali A, Rathert AC, Martín-Pinardel R, Bernal-Morales C, Alé-Chilet A, Barraso M, Marín-Martinez S, Feu-Basilio S, Rosinés-Fonoll J, Hernandez T, Vilá I, Castro-Dominguez R, Oliva C, Vinagre I, Ortega E, Gimenez M, Vellido A, Romero E, and Zarranz-Ventura J
- Abstract
Purpose: To evaluate the diagnostic accuracy of machine learning (ML) techniques applied to radiomic features extracted from OCT and OCT angiography (OCTA) images for diabetes mellitus (DM), diabetic retinopathy (DR), and referable DR (R-DR) diagnosis., Design: Cross-sectional analysis of a retinal image dataset from a previous prospective OCTA study (ClinicalTrials.govNCT03422965)., Participants: Patients with type 1 DM and controls included in the progenitor study., Methods: Radiomic features were extracted from fundus retinographies, OCT, and OCTA images in each study eye. Logistic regression, linear discriminant analysis, support vector classifier (SVC)-linear, SVC-radial basis function, and random forest models were created to evaluate their diagnostic accuracy for DM, DR, and R-DR diagnosis in all image types., Main Outcome Measures: Area under the receiver operating characteristic curve (AUC) mean and standard deviation for each ML model and each individual and combined image types., Results: A dataset of 726 eyes (439 individuals) were included. For DM diagnosis, the greatest AUC was observed for OCT (0.82, 0.03). For DR detection, the greatest AUC was observed for OCTA (0.77, 0.03), especially in the 3 × 3 mm superficial capillary plexus OCTA scan (0.76, 0.04). For R-DR diagnosis, the greatest AUC was observed for OCTA (0.87, 0.12) and the deep capillary plexus OCTA scan (0.86, 0.08). The addition of clinical variables (age, sex, etc.) improved most models AUC for DM, DR and R-DR diagnosis. The performance of the models was similar in unilateral and bilateral eyes image datasets., Conclusions: Radiomics extracted from OCT and OCTA images allow identification of patients with DM, DR, and R-DR using standard ML classifiers. OCT was the best test for DM diagnosis, OCTA for DR and R-DR diagnosis and the addition of clinical variables improved most models. This pioneer study demonstrates that radiomics-based ML techniques applied to OCT and OCTA images may be an option for DR screening in patients with type 1 DM., Financial Disclosures: Proprietary or commercial disclosure may be found after the references., (© 2022 Published by Elsevier Inc. on behalf of American Academy of Ophthalmology.)
- Published
- 2022
- Full Text
- View/download PDF
35. Automated Detection of Posterior Vitreous Detachment on OCT Using Computer Vision and Deep Learning Algorithms.
- Author
-
Li AL, Feng M, Wang Z, Baxter SL, Huang L, Arnett J, Bartsch DG, Kuo DE, Saseendrakumar BR, Guo J, and Nudleman E
- Abstract
Objective: To develop automated algorithms for the detection of posterior vitreous detachment (PVD) using OCT imaging., Design: Evaluation of a diagnostic test or technology., Subjects: Overall, 42 385 consecutive OCT images (865 volumetric OCT scans) obtained with Heidelberg Spectralis from 865 eyes from 464 patients at an academic retina clinic between October 2020 and December 2021 were retrospectively reviewed., Methods: We developed a customized computer vision algorithm based on image filtering and edge detection to detect the posterior vitreous cortex for the determination of PVD status. A second deep learning (DL) image classification model based on convolutional neural networks and ResNet-50 architecture was also trained to identify PVD status from OCT images. The training dataset consisted of 674 OCT volume scans (33 026 OCT images), while the validation testing set consisted of 73 OCT volume scans (3577 OCT images). Overall, 118 OCT volume scans (5782 OCT images) were used as a separate external testing dataset., Main Outcome Measures: Accuracy, sensitivity, specificity, F1-scores, and area under the receiver operator characteristic curves (AUROCs) were measured to assess the performance of the automated algorithms., Results: Both the customized computer vision algorithm and DL model results were largely in agreement with the PVD status labeled by trained graders. The DL approach achieved an accuracy of 90.7% and an F1-score of 0.932 with a sensitivity of 100% and a specificity of 74.5% for PVD detection from an OCT volume scan. The AUROC was 89% at the image level and 96% at the volume level for the DL model. The customized computer vision algorithm attained an accuracy of 89.5% and an F1-score of 0.912 with a sensitivity of 91.9% and a specificity of 86.1% on the same task., Conclusions: Both the computer vision algorithm and the DL model applied on OCT imaging enabled reliable detection of PVD status, demonstrating the potential for OCT-based automated PVD status classification to assist with vitreoretinal surgical planning., Financial Disclosures: Proprietary or commercial disclosure may be found after the references., (© 2022 Published by Elsevier Inc. on behalf of American Academy of Ophthalmology.)
- Published
- 2022
- Full Text
- View/download PDF
36. Unraveling the mystery of efficacy in Chinese medicine formula: New approaches and technologies for research on pharmacodynamic substances.
- Author
-
Li Y, Lin Z, Wang Y, Ju S, Wu H, Jin H, Ma S, and Zhang B
- Abstract
Traditional Chinese medicine (TCM) is the key to unlock treasures of Chinese civilization. TCM and its compound play a beneficial role in medical activities to cure diseases, especially in major public health events such as novel coronavirus epidemics across the globe. The chemical composition in Chinese medicine formula is complex and diverse, but their effective substances resemble "mystery boxes". Revealing their active ingredients and their mechanisms of action has become focal point and difficulty of research for herbalists. Although the existing research methods are numerous and constantly updated iteratively, there is remain a lack of prospective reviews. Hence, this paper provides a comprehensive account of existing new approaches and technologies based on previous studies with an in vitro to in vivo perspective. In addition, the bottlenecks of studies on Chinese medicine formula effective substances are also revealed. Especially, we look ahead to new perspectives, technologies and applications for its future development. This work reviews based on new perspectives to open horizons for the future research. Consequently, herbal compounding pharmaceutical substances study should carry on the essence of TCM while pursuing innovations in the field., (© 2022 The Authors.)
- Published
- 2022
- Full Text
- View/download PDF
37. Creating a Practical Transformational Change Management Model for Novel Artificial Intelligence-Enabled Technology Implementation in the Operating Room.
- Author
-
Smith TG, Norasi H, Herbst KM, Kendrick ML, Curry TB, Grantcharov TP, Palter VN, Hallbeck MS, and Cleary SP
- Abstract
Objective: To identify change management (CM) strategies for implementing novel artificial intelligence and similar novel technologies in operating rooms and create a new CM model for future trials and applications inspired by the abovementioned strategies and established models., Methods: Key phases of technology implementation were defined, and strategies for transformational CM were created and applied in a recent CM experience at our institution between October 15, 2020 and October 15, 2021. We appraised existing CM models and propose the newly created model., Results: The key phases of the technology implementation were as follows: (1) team assembly; (2) committee approvals; (3) CM; and (4) system installation and go-live. Key strategies were (1) assemble team with necessary expertise; (2) anticipate potential institutional cultural and regulatory hurdles; (3) add agility to project planning and execution; (4) accommodate institutional culture and regulations; (5) early clinical partner buy-in and stakeholder engagement; and (6) consistent communication, all of which contributed to the new CM model creation., Conclusion: Key CM strategies and a new CM model addressing the unique needs and characteristics of operating room novel technology implementation were identified and created. The new model may be customized and tested for individual institution and project's needs and characteristics., (© 2022 The Authors.)
- Published
- 2022
- Full Text
- View/download PDF
38. Detecting Glaucoma from Fundus Photographs Using Deep Learning without Convolutions: Transformer for Improved Generalization.
- Author
-
Fan R, Alipour K, Bowd C, Christopher M, Brye N, Proudfoot JA, Goldbaum MH, Belghith A, Girkin CA, Fazio MA, Liebmann JM, Weinreb RN, Pazzani M, Kriegman D, and Zangwill LM
- Abstract
Purpose: To compare the diagnostic accuracy and explainability of a Vision Transformer deep learning technique, Data-efficient image Transformer (DeiT), and ResNet-50, trained on fundus photographs from the Ocular Hypertension Treatment Study (OHTS) to detect primary open-angle glaucoma (POAG) and identify the salient areas of the photographs most important for each model's decision-making process., Design: Evaluation of a diagnostic technology., Subjects Participants and Controls: Overall 66 715 photographs from 1636 OHTS participants and an additional 5 external datasets of 16 137 photographs of healthy and glaucoma eyes., Methods: Data-efficient image Transformer models were trained to detect 5 ground-truth OHTS POAG classifications: OHTS end point committee POAG determinations because of disc changes (model 1), visual field (VF) changes (model 2), or either disc or VF changes (model 3) and Reading Center determinations based on disc (model 4) and VFs (model 5). The best-performing DeiT models were compared with ResNet-50 models on OHTS and 5 external datasets., Main Outcome Measures: Diagnostic performance was compared using areas under the receiver operating characteristic curve (AUROC) and sensitivities at fixed specificities. The explainability of the DeiT and ResNet-50 models was compared by evaluating the attention maps derived directly from DeiT to 3 gradient-weighted class activation map strategies., Results: Compared with our best-performing ResNet-50 models, the DeiT models demonstrated similar performance on the OHTS test sets for all 5 ground-truth POAG labels; AUROC ranged from 0.82 (model 5) to 0.91 (model 1). Data-efficient image Transformer AUROC was consistently higher than ResNet-50 on the 5 external datasets. For example, AUROC for the main OHTS end point (model 3) was between 0.08 and 0.20 higher in the DeiT than ResNet-50 models. The saliency maps from the DeiT highlight localized areas of the neuroretinal rim, suggesting important rim features for classification. The same maps in the ResNet-50 models show a more diffuse, generalized distribution around the optic disc., Conclusions: Vision Transformers have the potential to improve generalizability and explainability in deep learning models, detecting eye disease and possibly other medical conditions that rely on imaging for clinical diagnosis and management., (© 2022 Published by Elsevier Inc. on behalf of American Academy of Ophthalmology.)
- Published
- 2022
- Full Text
- View/download PDF
39. A novel image-based machine learning model with superior accuracy and predictability for knee arthroplasty loosening detection and clinical decision making.
- Author
-
Lau LCM, Chui ECS, Man GCW, Xin Y, Ho KKW, Mak KKK, Ong MTY, Law SW, Cheung WH, and Yung PSH
- Abstract
Background: Loosening is the leading cause of total knee arthroplasty (TKA) revision. This is a heavy burden toward the healthcare system owing to the difficulty in diagnosis and complications occurring from the delay management. Based on automatic analytical model building, machine learning, may potentially help to automatically recognize the risk of loosening based on radiographs alone. The aim of this study was to build an image-based machine-learning model for detecting TKA loosening., Methods: Image-based machine-learning model was developed based on ImageNet, Xception model and a TKA patient X-ray image dataset. Based on a dataset with TKA patient clinical parameters, another system was then created for developing the clinical-information-based machine learning model with random forest classifier. In addition, the Xception Model was pre-trained on the ImageNet database with python and TensorFlow deep learning library for the prediction of loosening. Class activation maps were also used to interpret the prediction decision made by model. Two senior orthopaedic specialists were invited to assess loosening from X-ray images for 3 attempts in setting up comparison benchmark., Result: In the image-based machine learning loosening model, the precision rate and recall rate were 0.92 and 0.96, respectively. While for the accuracy rate, 96.3% for visualization classification was observed. However, the addition of clinical-information-based model, with precision rate of 0.71 and recall rate of 0.20, did not further showed improvement on the accuracy. Moreover, as class activation maps showed corresponding signals over bone-implant interface that is loosened radiographically, this confirms that the current model utilized a similar image recognition pattern as that of inspection by clinical specialists., Conclusion: The image-based machine learning model developed demonstrated high accuracy and predictability of knee arthroplasty loosening. And the class activation heatmap matched well with the radiographic features used clinically to detect loosening, which highlighting its potential role in assisting clinicians in their daily practice. However, addition of clinical-information-based machine-learning model did not offer further improvement in detection. As far as we know, this is the first report of pure image-based machine learning model with high detection accuracy. Importantly, this is also the first model to show relevant class activation heatmap corresponding to loosening location., Translational Potential: The finding in this study indicated image-based machine learning model can detect knee arthroplasty loosening with high accuracy and predictability, which the class activation heatmap can potentially assist surgeons to identify the sites of loosening., Competing Interests: The authors have no conflicts of interest to disclose in relation to this article., (© 2022 The Chinese University of Hong Kong.)
- Published
- 2022
- Full Text
- View/download PDF
40. Artificial Intelligence Detection of Diabetic Retinopathy: Subgroup Comparison of the EyeArt System with Ophthalmologists' Dilated Examinations.
- Author
-
Lim JI, Regillo CD, Sadda SR, Ipp E, Bhaskaranand M, Ramachandra C, and Solanki K
- Abstract
Objective: To compare general ophthalmologists, retina specialists, and the EyeArt Artificial Intelligence (AI) system to the clinical reference standard for detecting more than mild diabetic retinopathy (mtmDR)., Design: Prospective, pivotal, multicenter trial conducted from April 2017 to May 2018., Participants: Participants were aged ≥ 18 years who had diabetes mellitus and underwent dilated ophthalmoscopy. A total of 521 of 893 participants met these criteria and completed the study protocol., Testing: Participants underwent 2-field fundus photography (macula centered, disc centered) for the EyeArt system, dilated ophthalmoscopy, and 4-widefield stereoscopic dilated fundus photography for reference standard grading., Main Outcome Measures: For mtmDR detection, sensitivity and specificity of EyeArt gradings of 2-field, fundus photographs and ophthalmoscopy grading versus a rigorous clinical reference standard comprising Reading Center grading of 4-widefield stereoscopic dilated fundus photographs using the ETDRS severity scale. The AI system provided automatic eye-level results regarding mtmDR., Results: Overall, 521 participants (999 eyes) at 10 centers underwent dilated ophthalmoscopy: 406 by nonretina and 115 by retina specialists. Reading Center graded 207 positive and 792 eyes negative for mtmDR. Of these 999 eyes, 26 eyes were ungradable by the EyeArt system, leaving 973 eyes with both EyeArt and Reading Center gradings. Retina specialists correctly identified 22 of 37 eyes as positive (sensitivity 59.5%) and 182 of 184 eyes as negative (specificity 98.9%) for mtmDR versus the EyeArt AI system that identified 36 of 37 as positive (sensitivity 97%) and 162 of 184 eyes as negative (specificity of 88%) for mtmDR. General ophthalmologists correctly identified 35 of 170 eyes as positive (sensitivity 20.6%) and 607 of 608 eyes as negative (specificity 99.8%) for mtmDR compared with the EyeArt AI system that identified 164 of 170 as positive (sensitivity 96.5%) and 525 of 608 eyes as negative (specificity 86%) for mtmDR., Conclusions: The AI system had a higher sensitivity for detecting mtmDR than either general ophthalmologists or retina specialists compared with the clinical reference standard. It can potentially serve as a low-cost point-of-care diabetic retinopathy detection tool and help address the diabetic eye screening burden., (© 2022 by the American Academy of Ophthalmology.)
- Published
- 2022
- Full Text
- View/download PDF
41. Automated urinary sediment detection for Fabry disease using deep-learning algorithms.
- Author
-
Uryu H, Migita O, Ozawa M, Kamijo C, Aoto S, Okamura K, Hasegawa F, Okuyama T, Kosuga M, and Hata K
- Abstract
Fabry disease is a congenital lysosomal storage disease, and most of these cases develop organ damage in middle age. There are some promising therapeutic options for this disorder, which can stabilize the progression of the disease. However, a long delay in diagnosis prevents early intervention, resulting in treatment failure. Because Fabry disease is a rare disease, it is not well recognized and disease specific screening tests are rarely performed. Hence, a novel approach to for detecting patients with a widely practiced clinical test is crucial for the early detection of the disease. Recently, decision support systems based on artificial intelligence (AI) have been developed in many clinical fields. However, the construction of these models requires datasets from a large number of samples; this aspect is one of the main obstacles in AI-based approaches for rare diseases. In this study, with a novel image amplification method to construct the dataset for AI-model training, we built the deep neural-network model to detect Fabry cases from their urine samples. Sensitivity, specificity, and the AUC of the models on validation dataset were 0.902 (95% CI, 0.900-0.903), 0.977 (0.950-0.980), and 0.968 (0.964-0.972), respectively. This model could also extract disease-specific findings that are interpretable with human recognition. These results indicate that we can apply novel AI models for rare diseases based on this image amplification method we developed. We expect this approach could contribute to the diagnosis of Fabry disease., Synopsis: This is the first reported AI-based decision support system to detect undiagnosed Fabry cases, and our new image amplification method will contribute to the AI models for other rare disorders., Competing Interests: All authors have no conflict of interest to declare., (© 2022 The Authors. Published by Elsevier Inc.)
- Published
- 2022
- Full Text
- View/download PDF
42. Frontier digital technology: Transforming noncommunicable disease prevention among youth.
- Author
-
Nguyen Hai T, Meyer L, McGuire H, Nguyen Thi Hong H, and Nguyen Thi L
- Abstract
Competing Interests: We declare no competing interests.
- Published
- 2022
- Full Text
- View/download PDF
43. Artificial intelligence performance in image-based ovarian cancer identification: A systematic review and meta-analysis.
- Author
-
Xu HL, Gong TT, Liu FH, Chen HY, Xiao Q, Hou Y, Huang Y, Sun HZ, Shi Y, Gao S, Lou Y, Chang Q, Zhao YH, Gao QL, and Wu QJ
- Abstract
Background: Accurate identification of ovarian cancer (OC) is of paramount importance in clinical treatment success. Artificial intelligence (AI) is a potentially reliable assistant for the medical imaging recognition. We systematically review articles on the diagnostic performance of AI in OC from medical imaging for the first time., Methods: The Medline, Embase, IEEE, PubMed, Web of Science, and the Cochrane library databases were searched for related studies published until August 1, 2022. Inclusion criteria were studies that developed or used AI algorithms in the diagnosis of OC from medical images. The binary diagnostic accuracy data were extracted to derive the outcomes of interest: sensitivity (SE), specificity (SP), and Area Under the Curve (AUC). The study was registered with the PROSPERO, CRD42022324611., Findings: Thirty-four eligible studies were identified, of which twenty-eight studies were included in the meta-analysis with a pooled SE of 88% (95%CI: 85-90%), SP of 85% (82-88%), and AUC of 0.93 (0.91-0.95). Analysis for different algorithms revealed a pooled SE of 89% (85-92%) and SP of 88% (82-92%) for machine learning; and a pooled SE of 88% (84-91%) and SP of 84% (80-87%) for deep learning. Acceptable diagnostic performance was demonstrated in subgroup analyses stratified by imaging modalities (Ultrasound, Magnetic Resonance Imaging, or Computed Tomography), sample size (≤300 or >300), AI algorithms versus clinicians, year of publication (before or after 2020), geographical distribution (Asia or non Asia), and the different risk of bias levels (≥3 domain low risk or < 3 domain low risk)., Interpretation: AI algorithms exhibited favorable performance for the diagnosis of OC through medical imaging. More rigorous reporting standards that address specific challenges of AI research could improve future studies., Funding: This work was supported by the Natural Science Foundation of China (No. 82073647 to Q-JW and No. 82103914 to T-TG), LiaoNing Revitalization Talents Program (No. XLYC1907102 to Q-JW), and 345 Talent Project of Shengjing Hospital of China Medical University (No. M0268 to Q-JW and No. M0952 to T-TG)., Competing Interests: All authors declare no competing interests., (© 2022 The Author(s).)
- Published
- 2022
- Full Text
- View/download PDF
44. Electrocardiogram-Artificial Intelligence and Immune-Mediated Necrotizing Myopathy: Predicting Left Ventricular Dysfunction and Clinical Outcomes.
- Author
-
Klein CJ, Ozcan I, Attia ZI, Cohen-Shelly M, Lerman A, Medina-Inojosa JR, Lopez-Jimenez F, Friedman PA, Milone M, and Shelly S
- Abstract
Objective: To characterize the utility of an existing electrocardiogram (ECG)-artificial intelligence (AI) algorithm of left ventricular dysfunction (LVD) in immune-mediated necrotizing myopathy (IMNM)., Patients and Methods: A retrospective cohort observational study was conducted within our tertiary-care neuromuscular clinic for patients with IMNM meeting European Neuromuscular Centre diagnostic criteria (January 1, 2000, to December 31, 2020). A validated AI algorithm using 12-lead standard ECGs to detect LVD was applied. The output was presented as a percent probability of LVD. Electrocardiograms before and while on immunotherapy were reviewed. The LVD-predicted probability scores were compared with echocardiograms, immunotherapy treatment response, and mortality., Results: The ECG-AI algorithm had acceptable accuracy in LVD prediction in 74% (68 of 89) of patients with IMNM with available echocardiograms (discrimination threshold, 0.74; 95% CI, 0.6-0.87). This translates into a sensitivity of 80.0% and specificity of 62.8% to detect LVD. Best cutoff probability prediction was 7 times more likely to have LVD (odds ratio, 6.75; 95% CI, 2.11-21.51; P =.001). Early detection occurred in 18% (16 of 89) of patients who initially had normal echocardiograms and were without cardiorespiratory symptoms, of which 6 subsequently advanced to LVD cardiorespiratory failure. The LVD probability scores improved for patients on immunotherapy (median slope, -3.96; R = -0.12; P =.002). Mortality risk was 7 times greater with abnormal LVD probability scores (hazard ratio, 7.33; 95% CI, 1.63-32.88; P =.009)., Conclusion: In IMNM, an AI-ECG algorithm assists detection of LVD, enhancing the decision to advance to echocardiogram testing, while also informing on mortality risk, which is important in the decision of immunotherapy escalation and monitoring., (© 2022 The Authors.)
- Published
- 2022
- Full Text
- View/download PDF
45. Small engine control by fuzzy logic.
- Author
-
Lee, S. H., Howlett, R. J., and Walters, S. D.
- Subjects
- *
COMBUSTION chambers , *ENGINES , *CARBURETORS , *ELECTRONIC control , *FUZZY algorithms , *CARBON monoxide , *AIR pollution - Abstract
Small spark-ignition gasoline-fuelled internal-combustion engines can be found all over the world performing in various roles including power generation, agricultural applications and motive power for small boats. To attain low cost, these engines are typically air-cooled, use simple carburettors to regulate the fuel supply, and employ magneto ignition systems. Electronic control, of the sort found in automotive engines, has seldom proved cost-effective for use with small engines. However, the future trend towards engines that have low levels of polluting exhaust emissions will make electronic control necessary, even for small engines. This paper describes a fuzzy control system applied to a small engine to achieve regulation of the fuel injection system. The system determines the amount of fuel required by a fuzzy algorithm that uses the engine speed and manifold air pressure as input values. The parameters of this fuzzy control paradigm were a collection of rules and fuzzy-set membership functions. These were intuitively comprehensible by the operator. This facilitated the calibration process, leading to quick and convenient tuning. Experimental results show that a considerable improvement in fuel regulation was achieved compared to the original carburettor-based engine configuration. In addition measurements of HC and CO emissions show a corresponding reduction. [ABSTRACT FROM AUTHOR]
- Published
- 2004
46. Surgical spectral imaging
- Author
-
Lena Maier-Hein, Daniel S. Elson, Danail Stoyanov, Geoffrey Jones, and Neil T. Clancy
- Subjects
CNN, Convolutional neural network ,EMCCD, Electron-multiplying charge-coupled device ,Hyperspectral imaging ,MRI, Magnetic resonance imaging ,Computer science ,Multispectral image ,GI, Gastrointestinal ,SVM, Support vector machine ,computer.software_genre ,09 Engineering ,030218 nuclear medicine & medical imaging ,VOF, Variable optical filter ,Multispectral imaging ,Machine Learning ,0302 clinical medicine ,Image Processing, Computer-Assisted ,NBI, Narrowband imaging ,11 Medical and Health Sciences ,AOTF, Acousto-optic tuneable filter ,DPF, Differential pathlength factor ,Radiological and Ultrasound Technology ,Minimally-invasive surgery ,DMD, Digital micromirror device ,MSI, Multispectral imaging ,Computer Graphics and Computer-Aided Design ,RGB, Red, green, blue ,INN, Invertible neural network ,Nuclear Medicine & Medical Imaging ,LOOCV, Leave-one-out cross validation ,CT, Computed tomography ,Computer Vision and Pattern Recognition ,FIGS, Fluorescence image-guided surgery ,Diagnostic Imaging ,medicine.medical_specialty ,FWHM, Full-width at half-maximum ,ComputingMethodologies_IMAGEPROCESSINGANDCOMPUTERVISION ,Health Informatics ,LED, Light emitting diode ,LCTF, Liquid crystal tuneable filter ,Machine learning ,Computational imaging ,Imaging phantom ,Article ,HSI, Hyperspectral imaging ,03 medical and health sciences ,Artificial Intelligence ,White light ,medicine ,Humans ,Radiology, Nuclear Medicine and imaging ,MIS, Minimally-invasive surgery ,Modalities ,business.industry ,Deep learning ,AI, Artificial intelligence ,SNR, Signal-to-noise ratio ,NIR, Near infrared ,OEM, Original equipment manufacturer ,SFDI, Spatial frequency domain imaging ,Spectral imaging ,Visualization ,SSI, Surgical spectral imaging ,sCMOS, Scientific complementary metal-oxide-semiconductor ,Artificial intelligence ,business ,computer ,030217 neurology & neurosurgery - Abstract
Highlights • Wider sensor availability and miniaturisation are pushing speed/resolution limits. • Small surgical datasets exist in many specialities but no standard format. • Data-driven analysis avoids modelling, improves speed, addresses uncertainty. • RGB-based functional imaging could exploit existing cameras, chip-on-tip devices. • Clinical validation with standardised devices and data needed for translation., Recent technological developments have resulted in the availability of miniaturised spectral imaging sensors capable of operating in the multi- (MSI) and hyperspectral imaging (HSI) regimes. Simultaneous advances in image-processing techniques and artificial intelligence (AI), especially in machine learning and deep learning, have made these data-rich modalities highly attractive as a means of extracting biological information non-destructively. Surgery in particular is poised to benefit from this, as spectrally-resolved tissue optical properties can offer enhanced contrast as well as diagnostic and guidance information during interventions. This is particularly relevant for procedures where inherent contrast is low under standard white light visualisation. This review summarises recent work in surgical spectral imaging (SSI) techniques, taken from Pubmed, Google Scholar and arXiv searches spanning the period 2013–2019. New hardware, optimised for use in both open and minimally-invasive surgery (MIS), is described, and recent commercial activity is summarised. Computational approaches to extract spectral information from conventional colour images are reviewed, as tip-mounted cameras become more commonplace in MIS. Model-based and machine learning methods of data analysis are discussed in addition to simulation, phantom and clinical validation experiments. A wide variety of surgical pilot studies are reported but it is apparent that further work is needed to quantify the clinical value of MSI/HSI. The current trend toward data-driven analysis emphasises the importance of widely-available, standardised spectral imaging datasets, which will aid understanding of variability across organs and patients, and drive clinical translation., Graphical abstract Image, graphical abstract
- Published
- 2020
47. Deep Learning in Dermatology: A Systematic Review of Current Approaches, Outcomes, and Limitations.
- Author
-
Jeong HK, Park C, Henao R, and Kheterpal M
- Abstract
Artificial intelligence (AI) has recently made great advances in image classification and malignancy prediction in the field of dermatology. However, understanding the applicability of AI in clinical dermatology practice remains challenging owing to the variability of models, image data, database characteristics, and variable outcome metrics. This systematic review aims to provide a comprehensive overview of dermatology literature using convolutional neural networks. Furthermore, the review summarizes the current landscape of image datasets, transfer learning approaches, challenges, and limitations within current AI literature and current regulatory pathways for approval of models as clinical decision support tools., (© 2022 The Authors.)
- Published
- 2022
- Full Text
- View/download PDF
48. Network metrics, structural dynamics and density functional theory calculations identified a novel Ursodeoxycholic Acid derivative against therapeutic target Parkin for Parkinson's disease.
- Author
-
Naha A, Banerjee S, Debroy R, Basu S, Ashok G, Priyamvada P, Kumar H, Preethi AR, Singh H, Anbarasu A, and Ramaiah S
- Abstract
Parkinson's disease (PD) has been designated as one of the priority neurodegenerative disorders worldwide. Although diagnostic biomarkers have been identified, early onset detection and targeted therapy are still limited. An integrated systems and structural biology approach were adopted to identify therapeutic targets for PD. From a set of 49 PD associated genes, a densely connected interactome was constructed. Based on centrality indices, degree of interaction and functional enrichments, LRRK2 , PARK2 , PARK7 , PINK1 and SNCA were identified as the hub-genes. PARK2 (Parkin) was finalized as a potent theranostic candidate marker due to its strong association (score > 0.99) with α-synuclein ( SNCA ), which directly regulates PD progression. Besides, modeling and validation of Parkin structure, an extensive virtual-screening revealed small (commercially available) inhibitors against Parkin. Molecule-258 (ZINC5022267) was selected as a potent candidate based on pharmacokinetic profiles, Density Functional Theory (DFT) energy calculations (ΔE = 6.93 eV) and high binding affinity (Binding energy = -6.57 ± 0.1 kcal/mol; Inhibition constant = 15.35 µM) against Parkin. Molecular dynamics simulation of protein-inhibitor complexes further strengthened the therapeutic propositions with stable trajectories (low structural fluctuations), hydrogen bonding patterns and interactive energies (>0kJ/mol). Our study encourages experimental validations of the novel drug candidate to prevent the auto-inhibition of Parkin mediated ubiquitination in PD., Competing Interests: The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper., (© 2022 Published by Elsevier B.V. on behalf of Research Network of Computational and Structural Biotechnology.)
- Published
- 2022
- Full Text
- View/download PDF
49. Implementation of a Large-Scale Image Curation Workflow Using Deep Learning Framework.
- Author
-
Domalpally A, Slater R, Barrett N, Voland R, Balaji R, Heathcote J, Channa R, and Blodi B
- Abstract
Purpose: The curation of images using human resources is time intensive but an essential step for developing artificial intelligence (AI) algorithms. Our goal was to develop and implement an AI algorithm for image curation in a high-volume setting. We also explored AI tools that will assist in deploying a tiered approach, in which the AI model labels images and flags potential mislabels for human review., Design: Implementation of an AI algorithm., Participants: Seven-field stereoscopic images from multiple clinical trials., Methods: The 7-field stereoscopic image protocol includes 7 pairs of images from various parts of the central retina along with images of the anterior part of the eye. All images were labeled for field number by reading center graders. The model output included classification of the retinal images into 8 field numbers. Probability scores (0-1) were generated to identify misclassified images, with 1 indicating a high probability of a correct label., Main Outcome Measures: Agreement of AI prediction with grader classification of field number and the use of probability scores to identify mislabeled images., Results: The AI model was trained and validated on 17 529 images and tested on 3004 images. The pooled agreement of field numbers between grader classification and the AI model was 88.3% (kappa, 0.87). The pooled mean probability score was 0.97 (standard deviation [SD], 0.08) for images for which the graders agreed with the AI-generated labels and 0.77 (SD, 0.19) for images for which the graders disagreed with the AI-generated labels ( P < 0.0001). Using receiver operating characteristic curves, a probability score of 0.99 was identified as a cutoff for distinguishing mislabeled images. A tiered workflow using a probability score of < 0.99 as a cutoff would include 27.6% of the 3004 images for human review and reduce the error rate from 11.7% to 1.5%., Conclusions: The implementation of AI algorithms requires measures in addition to model validation. Tools to flag potential errors in the labels generated by AI models will reduce inaccuracies, increase trust in the system, and provide data for continuous model development., (© 2022 by the American Academy of Ophthalmology.)
- Published
- 2022
- Full Text
- View/download PDF
50. Detection of Nonexudative Macular Neovascularization on Structural OCT Images Using Vision Transformers.
- Author
-
Kihara Y, Shen M, Shi Y, Jiang X, Wang L, Laiginhas R, Lyu C, Yang J, Liu J, Morin R, Lu R, Fujiyoshi H, Feuer WJ, Gregori G, Rosenfeld PJ, and Lee AY
- Abstract
Purpose: A deep learning model was developed to detect nonexudative macular neovascularization (neMNV) using OCT B-scans., Design: Retrospective review of a prospective, observational study., Participants: Normal control eyes and patients with age-related macular degeneration (AMD) with and without neMNV., Methods: Swept-source OCT angiography (SS-OCTA) imaging (PLEX Elite 9000, Carl Zeiss Meditec, Inc) was performed using the 6 × 6-mm scan pattern. Individual B-scans were annotated to distinguish between drusen and the double-layer sign (DLS) associated with the neMNV. The machine learning model was tested on a dataset graded by humans, and model performance was compared with the human graders., Main Outcome Measures: Intersection over Union (IoU) score was measured to evaluate segmentation network performance. Area under the receiver operating characteristic curve values, sensitivity, specificity, and positive predictive value (PPV) and negative predictive value (NPV) were measured to assess the performance of the final classification performance. Chance-corrected agreement between the algorithm and the human grader determinations was measured with Cohen's kappa., Results: A total of 251 eyes from 210 patients, including 182 eyes with DLS and 115 eyes with drusen, were used for model training. Of 125 500 B-scans, 6879 B-scans were manually annotated. A vision transformer segmentation model was built to extract DLS and drusen from B-scans. The extracted prediction masks from all B-scans in a volume were projected to an en face image, and an eye-level projection map was obtained for each eye. A binary classification algorithm was established to identify eyes with neMNV from the projection map. The algorithm achieved 82%, 90%, 79%, and 91% sensitivity, specificity, PPV, and NPV, respectively, on a separate test set of 100 eyes that were evaluated by human graders in a previous study. The area under the curve value was calculated as 0.91 (95% confidence interval, 0.85-0.98). The results of the algorithm showed excellent agreement with the senior human grader (kappa = 0.83, P < 0.001) and moderate agreement with the junior grader consensus (kappa = 0.54, P < 0.001)., Conclusions: Our network (code is available at https://github.com/uw-biomedical-ml/double_layer_vit) was able to detect the presence of neMNV from structural B-scans alone by applying a purely transformer-based model., (© 2022 by the American Academy of Ophthalmology.)
- Published
- 2022
- Full Text
- View/download PDF
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.